
<html lang="en"     class="pb-page"  data-request-id="0369968e-d133-4eb3-99e5-ecef3578f7f9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm400194n;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR)" /></meta><meta name="dc.Creator" content="Anthony A.  Estrada" /></meta><meta name="dc.Creator" content="Daniel G.  Shore" /></meta><meta name="dc.Creator" content="Elizabeth  Blackwood" /></meta><meta name="dc.Creator" content="Yung-Hsiang  Chen" /></meta><meta name="dc.Creator" content="Gauri  Deshmukh" /></meta><meta name="dc.Creator" content="Xiao  Ding" /></meta><meta name="dc.Creator" content="Antonio G.  DiPasquale" /></meta><meta name="dc.Creator" content="Jennifer A.  Epler" /></meta><meta name="dc.Creator" content="Lori S.  Friedman" /></meta><meta name="dc.Creator" content="Michael F. T.  Koehler" /></meta><meta name="dc.Creator" content="Lichuan  Liu" /></meta><meta name="dc.Creator" content="Shiva  Malek" /></meta><meta name="dc.Creator" content="Jim  Nonomiya" /></meta><meta name="dc.Creator" content="Daniel F.  Ortwine" /></meta><meta name="dc.Creator" content="Zhonghua  Pei" /></meta><meta name="dc.Creator" content="Steve  Sideris" /></meta><meta name="dc.Creator" content="Frederic  St-Jean" /></meta><meta name="dc.Creator" content="Lan  Trinh" /></meta><meta name="dc.Creator" content="Tom  Truong" /></meta><meta name="dc.Creator" content="Joseph P.  Lyssikatos" /></meta><meta name="dc.Description" content="We have recently reported a series of tetrahydroquinazoline (THQ) mTOR inhibitors that produced a clinical candidate 1 (GDC-0349). Through insightful design, we hoped to discover and synthesize a n..." /></meta><meta name="Description" content="We have recently reported a series of tetrahydroquinazoline (THQ) mTOR inhibitors that produced a clinical candidate 1 (GDC-0349). Through insightful design, we hoped to discover and synthesize a n..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 29, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400194n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400194n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400194n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400194n" /></link>
        
    
    

<title>Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400194n" /></meta><meta property="og:title" content="Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0015.jpeg" /></meta><meta property="og:description" content="We have recently reported a series of tetrahydroquinazoline (THQ) mTOR inhibitors that produced a clinical candidate 1 (GDC-0349). Through insightful design, we hoped to discover and synthesize a new series of small molecule inhibitors that could attenuate CYP3A4 time-dependent inhibition commonly observed with the THQ scaffold, maintain or improve aqueous solubility and oral absorption, reduce free drug clearance, and selectively increase mTOR potency. Through key in vitro and in vivo studies, we demonstrate that a pyrimidoaminotropane based core was able to address each of these goals. This effort culminated in the discovery of 20 (GNE-555), a highly potent, selective, metabolically stable, and efficacious mTOR inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400194n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400194n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400194n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400194n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400194n&amp;href=/doi/10.1021/jm400194n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3090-3101</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4001693" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400195y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+A.++Estrada">Anthony A. Estrada</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+G.++Shore">Daniel G. Shore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Blackwood">Elizabeth Blackwood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yung-Hsiang++Chen">Yung-Hsiang Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gauri++Deshmukh">Gauri Deshmukh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao++Ding">Xiao Ding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio+G.++DiPasquale">Antonio G. DiPasquale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+A.++Epler">Jennifer A. Epler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori+S.++Friedman">Lori S. Friedman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+F.+T.++Koehler">Michael F. T. Koehler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lichuan++Liu">Lichuan Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shiva++Malek">Shiva Malek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim++Nonomiya">Jim Nonomiya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+F.++Ortwine">Daniel F. Ortwine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhonghua++Pei">Zhonghua Pei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steve++Sideris">Steve Sideris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederic++St-Jean">Frederic St-Jean</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lan++Trinh">Lan Trinh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tom++Truong">Tom Truong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Lyssikatos">Joseph P. Lyssikatos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of <sup>†</sup>Discovery Chemistry, <sup>‡</sup>Translational Oncology, <sup>§</sup>Biochemical and Cellular Pharmacology, and <sup>∥</sup>Drug Metabolism and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">⊥</span> <span class="aff-text">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis Hall, Berkeley, California 94720, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 650-225-4934. E-mail: <a href="/cdn-cgi/l/email-protection#d4b1a7a0a6b5b0b5fab5baa0bcbbbaad94b3b1bab1fab7bbb9"><span class="__cf_email__" data-cfemail="781d0b0c0a191c195619160c10171601381f1d161d561b1715">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400194n&amp;href=/doi/10.1021%2Fjm400194n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3090–3101</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 8, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 February 2013</li><li><span class="item_label"><b>Published</b> online</span>29 March 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400194n" title="DOI URL">https://doi.org/10.1021/jm400194n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3090%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnthony%2BA.%2BEstrada%252C%2BDaniel%2BG.%2BShore%252C%2BElizabeth%2BBlackwood%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D7%26contentID%3Djm400194n%26title%3DPyrimidoaminotropanes%2Bas%2BPotent%252C%2BSelective%252C%2Band%2BEfficacious%2BSmall%2BMolecule%2BKinase%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3101%26publicationDate%3DApril%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400194n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2574</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400194n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;A. Estrada&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;G. Shore&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Blackwood&quot;},{&quot;first_name&quot;:&quot;Yung-Hsiang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Gauri&quot;,&quot;last_name&quot;:&quot;Deshmukh&quot;},{&quot;first_name&quot;:&quot;Xiao&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;G. DiPasquale&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;A. Epler&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;S. Friedman&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;F. T. Koehler&quot;},{&quot;first_name&quot;:&quot;Lichuan&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Shiva&quot;,&quot;last_name&quot;:&quot;Malek&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Nonomiya&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;F. Ortwine&quot;},{&quot;first_name&quot;:&quot;Zhonghua&quot;,&quot;last_name&quot;:&quot;Pei&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;Sideris&quot;},{&quot;first_name&quot;:&quot;Frederic&quot;,&quot;last_name&quot;:&quot;St-Jean&quot;},{&quot;first_name&quot;:&quot;Lan&quot;,&quot;last_name&quot;:&quot;Trinh&quot;},{&quot;first_name&quot;:&quot;Tom&quot;,&quot;last_name&quot;:&quot;Truong&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Lyssikatos&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;3090-3101&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400194n&quot;},&quot;abstract&quot;:&quot;We have recently reported a series of tetrahydroquinazoline (THQ) mTOR inhibitors that produced a clinical candidate 1 (GDC-0349). Through insightful design, we hoped to discover and synthesize a new series of small molecule inhibitors that could attenuate CYP3A4 time-dependent inhibition commonly observed with the THQ scaffold, maintain or improve aqueous solubility and oral absorption, reduce free drug clearance, and selectively increase mTOR potency. Through key in vitro and in vivo studies, we demonstrate that a pyrimidoaminotropane based core was able to address each of these goals. This effort culminated in the discovery of 20 (GNE-555), a highly potent, selective, metabolically stable, and efficacious mTOR inhibitor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400194n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400194n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400194n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400194n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400194n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400194n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400194n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400194n&amp;href=/doi/10.1021/jm400194n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400194n" /></input><a href="/doi/pdf/10.1021/jm400194n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400194n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400194n%26sid%3Dliteratum%253Aachs%26pmid%3D23473235%26genre%3Darticle%26aulast%3DEstrada%26date%3D2013%26atitle%3DPyrimidoaminotropanes%2Bas%2BPotent%252C%2BSelective%252C%2Band%2BEfficacious%2BSmall%2BMolecule%2BKinase%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D7%26spage%3D3090%26epage%3D3101%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jmcmar.2013.56.issue-7/production/jmcmar.2013.56.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have recently reported a series of tetrahydroquinazoline (THQ) mTOR inhibitors that produced a clinical candidate <b>1</b> (GDC-0349). Through insightful design, we hoped to discover and synthesize a new series of small molecule inhibitors that could attenuate CYP3A4 time-dependent inhibition commonly observed with the THQ scaffold, maintain or improve aqueous solubility and oral absorption, reduce free drug clearance, and selectively increase mTOR potency. Through key in vitro and in vivo studies, we demonstrate that a pyrimidoaminotropane based core was able to address each of these goals. This effort culminated in the discovery of <b>20</b> (GNE-555), a highly potent, selective, metabolically stable, and efficacious mTOR inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mammalian or mechanistic target of rapamycin (mTOR) is a clinically validated target for treatment of human cancers such as renal cell carcinoma, endometrial cancer, and mantle cell lymphoma. The PI3K-AKT-mTOR signaling pathway represents a major growth and survival pathway that is dysregulated in many human cancers, is involved in regulating the translation of proteins associated with drug resistance, and controls cell cycle progression and cell survival.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To date, only the macrolide rapamycin analogues (rapalogues) have been clinically approved as mTOR inhibitors. However, the use of rapalogues as a single-agent therapy in major solid tumors has resulted in only modest objective response rates with the exception of everolimus in combination with exemestane for treatment of hormone receptor positive breast cancer.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The proposed, and recently supported,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> rationale for these observations is that rapalogues only inhibit one of two functional multiprotein complexes, mTORC1. The second complex, mTORC2, which has been shown to be an important driver for cancer cell growth and survival, is unaffected by rapalogues. Additionally, there is a postulated feedback loop between mTORC1 and Akt in certain tumor cells whereby mTORC1 inhibition results in up-regulation of Akt activity and enhanced cell survival.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Thus, the development of a small molecule that has the potential to inhibit both mTORC1 and mTORC2 has been the focus of several drug discovery efforts,<a onclick="showRef(event, 'cit8a cit8b cit8c cit8d cit8e cit8f cit8g cit8h cit8i cit8j cit8k cit8l cit8m cit8n cit8o cit8p cit8q cit8r cit8s cit8t cit8u cit8v cit8w cit8x'); return false;" href="javascript:void(0);" class="ref cit8a cit8b cit8c cit8d cit8e cit8f cit8g cit8h cit8i cit8j cit8k cit8l cit8m cit8n cit8o cit8p cit8q cit8r cit8s cit8t cit8u cit8v cit8w cit8x">(8a-8x)</a> including our own, and is currently being tested in the clinic.</div><div class="NLM_p">We previously disclosed a variety of saturated-fused pyrimidine mTOR inhibitors including dihydrofuropyrimidines,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> dihydropyrrolopyrimidines,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and tetrahydroquinazolines (THQs).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> The last culminated in the discovery of clinical candidate <b>1</b> (GDC-0349, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> During the optimization of the THQ series, we discovered a few potential issues such as CYP3A4 time-dependent inhibition (TDI) that plagued many of the compounds in this series as highlighted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. In vitro CYP3A4 TDI raises a potential for clinical drug–drug interactions and idiosyncratic adverse drug reactions.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> In an attempt to attenuate the commonly observed TDI with the THQ scaffold, as well as address additional potential concerns while maintaining the desirable attributes of the THQ series, we rationalized that a bicyclic system such as the pyrimidoaminotropane (PAT) scaffold could fulfill this role. Through installation of the ethylene bridge at the carbon atoms adjacent to the piperidine nitrogen, we hypothesized that we would observe the following: (a) elimination of two potential sites of reactive metabolite formation due to the high strain energy of a resulting iminium bridgehead double bond (Bredt’s rule<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a>); (b) an increase in sp<sup>3</sup> character and a decrease in planarity to maintain or improve aqueous solubility;<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> (c) an increase in metabolic stability; (d) a selective increase in mTOR potency through additional lipophilic contacts with a postulated small hydrophobic patch above the plane of the THQ saturated ring system (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Additional key ligand–protein interactions that contribute to selective mTOR potency have been previously described and are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of clinical candidate <b>1</b> and one of two potential reactive iminium species of the THQ series and design rationale for PATs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Depiction of 7-aza-PAT <b>20</b> (GNE-555) (yellow) in the active site of the mTOR homology model<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> with residues important for binding and selectivity vs PI3Kγ shown. View is edge-on to the plane of the inhibitor bicyclic ring. Hydrogen bonds to the protein are shown as thin dashed lines. A vdW surface on the protein color-coded by lipophilic potential (tan-brown = lipophilic, cyan-blue = polar, green = between lipophilic and polar) has been added. Note the proximity of the lipophilic portions of the tropane and (<i>S</i>)-3-methylmorpholine ring to the lipophilic portions of the protein. The oxetane ring extends toward solvent. Image was generated using Benchware3DExplorer (Tripos Inc., St. Louis, MO).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While the PAT scaffold was unknown in the literature at the time of our investigation, we drew inspiration from a pyrimidine synthetic methodology disclosed by Movassaghi.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> We were successful in developing a modification of this protocol to enable flexible and rapid access to <i>N</i>-vinyl tertiary enamide starting materials.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This methodology provided us with the opportunity to synthesize the desired PAT moiety and quickly test our hypothesis. As depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, we decided to initially pursue 6-aza-PATs, as <i>N</i>-H tropinone is commercially available, and access to the corresponding 7-aza-PAT starting material required a multistep synthesis. Thus, <i>N</i>-Alloc tropinone <b>2</b> was condensed with <i>p</i>-methoxybenzylamine in the presence of Ti(OEt)<sub>4</sub>, and the resulting imine/enamine intermediate is captured with <i>p</i>-nitrobenzoyl chloride to provide tertiary enamide <b>3</b>. This is followed by pyrimidine formation with the concomitant addition of (<i>S</i>)-3-methylmorpholine, which provides enhanced mTOR potency and selectivity, relative to morpholine, over those of closely related kinases such as PI3 kinases as previously described.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Nitro reduction, ethyl urea formation, and <i>N</i>-Alloc deprotection set the stage for various late stage diversifications of the tropane nitrogen.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 6-Aza-PATs via Pyrimidine Synthetic Methodology<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PMBNH<sub>2</sub>, Ti(OEt)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 16 h, then Et<sub>3</sub>N, <i>p</i>-NO<sub>2</sub>BzCl, 0–25 °C, 84%; (b) (<i>S</i>)-3-methylmorpholine-4-carbonitrile, Tf<sub>2</sub>O, 2-ClPyr, CH<sub>2</sub>Cl<sub>2</sub>, −78 to 25 °C, 40%; (c) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, Δ; (d) triphosgene, Et<sub>3</sub>N, 1,2-DCE, 0–70 °C, then EtNH<sub>2</sub>·HCl, 25 °C; (e) Pd(PPh<sub>3</sub>)<sub>4</sub>, morpholine, THF, 0 °C; (f) see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. 6-Aza PAT SAR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0012.gif" alt="" id="GRAPHIC-d482e585-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Assays described in refs <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a> and <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a>. All biochemical and cellular assay results represent the geometric mean of a minimum of two determinations, and these assays generally produced results within 3-fold of the reported mean.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Assayed in NCI-PC3 cell line.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">(5<i>S</i>,8<i>R</i>)-Tropane isomer.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Ratio of <i>K</i><sub>i</sub> values of PI3Kα and PI3Kδ over mTOR.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">TDI IC<sub>50</sub> is the concentration of inhibitor that supports 50% inhibition of activity following a 30 min preincubation in the presence of NADPH.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">IC<sub>50</sub> could not be measured.</p></div></div><div></div></div><div class="NLM_p">The more active and selective (5<i>R</i>,8<i>S</i>)-6-aza-PAT diastereomers shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> generally demonstrated good in vitro biochemical (mTOR <i>K</i><sub>i</sub> < 15 nM), cellular (≤30 nM), and antiproliferative (<500 nM) activities. While simple <i>N</i>-alkyl substitution provided mTOR inhibitors with good activity and selectivity profiles (<b>8</b>–<b>10</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), oxetanyl, sulfonyl, and acetyl derivatives (<b>11</b>–<b>14</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were synthesized to attenuate the basicity of the tropane nitrogen and potential risk for hERG off-target activity. The assigned 5<i>R</i>,8<i>S</i> isomers always displayed a superior PI3K/mTOR selectivity index (>100-fold over mTOR) compared to the alternative 5<i>S</i>,8<i>R</i> diastereomer. The observed selectivity, along with docking analyses, was used to assign the stereochemistry of the 6-aza-PAT stereoisomers. Docking showed that both stereoisomers could be accommodated by mTOR, whereas one isomer showed a close contact with a Trp residue (W812) in PI3Kγ at the position analogous to K2171 of the mTOR active site (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The less bulky K2171 residue in mTOR results in a larger binding cavity that can better accommodate the bridged bicyclic ring and oxetane substituent. Consistent with this observation, 6-aza-PAT diastereomers containing smaller N-substituents displayed reduced selectivity differences (e.g., see <i>N</i>-Me isomers <b>8</b> and <b>9</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of low energy docked models of tropanes <b>11</b> (pink) and <b>12</b> (green). PI3Kγ residues are in cyan, and the corresponding mTOR residues are in gray. mTOR numbering is shown. Note the closer contact of the oxetane ring to the Trp ring in PI3Kγ (W812 in PI3Kγ; K2171 in mTOR) for <b>11</b>, consistent with its increased mTOR selectivity relative to <b>12</b>. Both <b>11</b> and <b>12</b> are well accommodated by mTOR because of the less bulky K2171 residue providing a larger binding cavity. In this view, W2239 in mTOR occurs behind the inhibitor oxetane rings of <b>11</b> and <b>12</b> and does not sterically clash. Image was generated using Benchware3DExplorer (Tripos Inc., St. Louis, MO).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the promising activity and selectivity profiles, the 6-aza-PATs shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> also exhibited little to no CYP3A4 TDI risk and good aqueous solubility (all kinetic solubilities of >75 μM). Furthermore, we were encouraged by the collective profiles of the 6-aza-PATs when compared to the corresponding 6-aza-THQ analogues. This is exemplified in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> with <b>11</b> and 6-aza-THQ, <b>15</b>. The CYP3A4 TDI was attenuated, the aqueous solubility improved, and a 4-5 fold increase in antiproliferative activity was noted.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> These encouraging results provided confidence that the PAT scaffold could address the inherent issues associated with the lead THQ series. Additionally, we already knew that the 7-aza-THQ analogues were superior to the 6-aza-THQ variants.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Before testing this relationship in the 7-aza-PAT series, which required a multistep synthesis to access the tropinone starting material, we wanted to obtain in vivo validation for the 6-aza-PAT series.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Matched pair comparison of 6-aza-THQ (<b>15</b>) and 6-aza-PAT (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pharmacokinetic profiles of <b>8</b> and <b>9</b> were assessed in mouse PK studies. Both analogues demonstrated low unbound clearance values (207 and 53 mL min<sup>–1</sup> kg<sup>–1</sup>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and exhibited a good in vitro–in vivo correlation with mouse microsomal stability data. Additionally, these two compounds had excellent bioavailability (114% and 82%, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and high free fraction in human plasma. Inhibitor <b>8</b> was chosen for in vivo target modulation studies of the mTOR signaling pathway using NCR nude mice inoculated subcutaneously with NCI-PC3 prostate cancer xenografts. The PI3K/Akt/mTOR pathway is activated in this PTEN-null cell line, and mTOR inhibitors have previously been reported to be effective in this model.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Dose dependent on-target reductions of pS6RP (mTORC1 readout) and pAkt (mTORC2 readout) were demonstrated from 25 to 50 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), with 50 and 100 mg/kg drug level cohorts demonstrating reduced pAkt and pS6RP recovery at the 6 and 10 h time points. This inhibition correlated with the plasma concentration, where total plasma levels of >1 μM (unbound plasma levels of >0.32 μM) translate to >50% knockdown of both markers. With these positive results, the focus now shifted to the regioisomeric 7-aza-PAT series that we hoped would follow the same pattern as the THQ series and yield improved overall profiles compared to the 6-aza-PATs.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Mouse PK Profiles of 6-Aza-PATs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">iv (1 mg/kg)</th><th class="rowsep1 colsep0" align="center">po (5 mg/kg)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">microsomes Cl<sub>hep</sub> <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (mL min<sup>–1</sup> kg<sup>–1</sup>) for h/r/m<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub>(L kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">PPB (%) for h/r/m<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">12/18/42</td><td class="colsep0 rowsep0" align="left">67 (207)</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">0.80</td><td class="colsep0 rowsep0" align="left">114</td><td class="colsep0 rowsep0" align="left">38/27/68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">15/28/58</td><td class="colsep0 rowsep0" align="left">34 (53)</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">1.07</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">19/20/46</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compound dosed po as a suspension in MCT and iv as a 60% PEG solution.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Cl<sub>hep</sub> predicted from incubation with microsomes.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">h/r/m = human/rat/mouse.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/[(100 – % mouse PPB)/100].</p></div></div></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo target modulation of mTOR pathway in NCI-PC3 human prostate tumor xenografts with <b>8</b> administered as a single oral dose to tumor-bearing mice. Plasma samples were collected at 1, 6, and 10 h postdose and analyzed for drug exposure and PD biomarker modulation. Target inhibition was calculated relative to the average time-matched vehicle control. Error bars indicate ± standard error of the mean. Four mice were dosed, and phosphoprotein levels were measured in duplicate samples for each mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 7-Aza-PATs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a></p></p></figure><div class="NLM_p">In order to access the 7-aza-PAT scaffold, we first synthesized known 8-benzyl-8-azabicyclo[3.2.1]octan-2-one (<b>16</b>, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>),<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> and then using similar chemistry described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> for the 6-aza-PAT series,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> we were able to target a diverse collection of 7-aza-PAT analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) via intermediate <b>17</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). We were pleased to find that the 7-aza-PAT analogues with the desirable (6<i>S</i>,9<i>R</i>) bridgehead stereochemistry demonstrated significantly increased activity in the biochemical (mTOR <i>K</i><sub>i</sub> < 3 nM), cellular (<4 nM), and antiproliferative (<85 nM) assays as well as exquisite selectivity over PI3 kinases. The absolute stereochemistry of <b>20</b> was assigned through small molecule X-ray crystallographic analysis, and other 7-aza-PATs were assigned by analogy (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for ORTEP figure and X-ray collection data). Similar to the 6-aza-PAT analogues, oxetanyl (<b>20,</b> Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), sulfonyl (<b>21</b>), acetyl (<b>22</b>), and additional N-capping groups (<b>23</b>, <b>24</b>) were designed to attenuate the basicity of the tropane nitrogen. Modeling studies showed the tropane N-substituent of the 7-aza-PATs was pointing out toward solvent (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Consistent with this, all of the R-groups shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were tolerated with respect to potency and selectivity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. 7-Aza-PAT SAR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0013.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0014.gif" alt="" id="GRAPHIC-d482e1047-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Assays described in refs <a onclick="showRef(event, 'ref9 ref22'); return false;" href="javascript:void(0);" class="ref ref9 ref22">9 and 22</a>. All biochemical and cellular assay results represent the geometric mean of a minimum of two determinations, and these assays generally produced results within 3-fold of the reported mean.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Assayed in NCI-PC3 cell line.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">(6<i>R</i>,9<i>S</i>)-Tropane isomer.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Ratio of <i>K</i><sub>i</sub> values of PI3Kα and PI3Kδ over mTOR.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">TDI IC<sub>50</sub> is the concentration of inhibitor that supports 50% inhibition of activity following a 30 min preincubation in the presence of NADPH.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">IC<sub>50</sub> could not be measured.</p></div></div><div></div></div><div class="NLM_p">The mouse pharmacokinetic profiles of 7-aza-PATs <b>18</b> and <b>20</b>–<b>23</b> were then assessed (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These compounds have very low total and unbound mouse plasma clearance values as well as good to excellent oral bioavailability. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A and Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B illustrate the matched molecular pairs of 7-aza-PATs <b>20</b>–<b>23</b> with 7-aza-THQ counterparts where the N-substituent is identical.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34">(30-34)</a> This clearly exemplifies the improved profile of the 7-aza-PATs with respect to increasing cellular potency (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A) and reducing metabolic clearance (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). Additionally, all 7-aza-PATs had good aqueous solubility and were either devoid of 3A4 TDI liabilities (as well as 2C9, 2C19, and 1A2 CYP isoforms) or demonstrated minimal risk. The balance of desirable cellular activity and in vivo free drug clearance and oral exposure for <b>20</b> justified evaluation in higher species PK, PK/PD, and TGI studies.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mouse PK Profiles of 7-Aza-PATs<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">iv (1 mg/kg)</th><th class="rowsep1 colsep0" align="center" char=".">po (5 mg/kg)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">microsomes Cl<sub>hep</sub> <a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (mL min<sup>–1</sup> kg<sup>–1</sup>) for h/r/m<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub>(L kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">PPB (%) for h/r/m<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">14/22/50</td><td class="colsep0 rowsep0" align="left">24 (165)</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">133</td><td class="colsep0 rowsep0" align="left">_/68/86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">14/27/51</td><td class="colsep0 rowsep0" align="left">4.8 (38)</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="left">85/76/87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">11/26/49</td><td class="colsep0 rowsep0" align="left">17.8 (342)</td><td class="colsep0 rowsep0" align="char" char=".">1.59</td><td class="colsep0 rowsep0" align="char" char=".">1.02</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="left">86/90/95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">15/24/42</td><td class="colsep0 rowsep0" align="left">4.62 (200)</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="left">84/84/98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">17/31/69</td><td class="colsep0 rowsep0" align="left">9.38 (134)</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="left">73/79/93</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Compounds dosed po as a suspension in MCT and iv as DMSO/Cremophor EL/H<sub>2</sub>O (5/5/90) solution.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Cl<sub>hep</sub> predicted from incubation with microsomes.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">h/r/m = human/rat/mouse.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/[(100 – % mouse PPB)/100].</p></div></div></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Direct comparison of NCI-PC3 antiproliferative cellular activities of 7-aza-PAT (<b>20</b>–<b>23</b>, green) and respective 7-aza-THQ (red) matched pairs. (B) Direct comparison of in vivo mouse plasma clearances of 7-aza-PAT (<b>20</b>–<b>23</b>, green) and respective 7-aza-THQ (red) matched pairs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As had been observed in rodents, the dog PK profile of <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) demonstrated a low unbound blood clearance of 44 mL min<sup>–1</sup> kg<sup>–1</sup> when dosed intravenously, as well as a total blood clearance that is only 20% of hepatic blood flow. This increased our confidence in the ability to predict the human PK profile for <b>20</b>. Inhibitor <b>20</b> was then dosed up to 5 mg/kg along with our lead clinical candidate <b>1</b> (80 mg/kg) as a positive control in the PC3 prostate tumor cell line in mice with plasma sample collection at 6 h postdose (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This provided in vivo validation that the activity of compound <b>20</b> was on-target and that pharmacodynamic knockdown of pAkt and pS6RP correlated well with plasma exposure. Selectivity for mTOR was demonstrated with <b>20</b> in a representative panel of 55 kinases at 1 μM (667-fold over mTOR <i>K</i><sub>i</sub>) where only one kinase was inhibited at greater than 50% (PI3Kδ, 51%). We then evaluated the ability of <b>20</b> to induce tumor growth inhibition in a MCF7neo/HER2 breast cancer model (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B) and compared these results to the efficacy shown by <b>1</b> with the same cell line. After 14 days of QD dosing, significant tumor growth suppression (57% TGI) was observed at only 12.5 mg/kg of inhibitor <b>20</b>. In separate studies with <b>1</b>, the required dose to approach approximately the same tumor volume suppression (60% TGI) was 37 mg/kg, translating to a calculated minimum efficacious dose (mED) of 27.4 mg/kg.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Comparatively, <b>20</b> requires less than half of this dose to achieve equivalent efficacy with a calculated mED of 12.3 mg/kg in the MCF7 breast cancer model.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Dog iv PK Profile of <b>20</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">microsomes Cl<sub>hep</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">Cl<sub>b</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> (Cl<sub>bu</sub>)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub>(L kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">6 (44)</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">3.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Dosed iv as 40% PEG/60% H<sub>2</sub>O solution.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Cl<sub>hep</sub> predicted from incubation with microsomes.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Cl<sub>b</sub> = blood clearance = plasma clearance/blood plasma partitioning.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Cl<sub>bu</sub> = unbound blood clearance = total blood clearance/[(100 – % mouse PPB)/100].</p></div></div></div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) In vivo target modulation of mTOR pathway in NCI-PC3 human prostate tumor xenografts with <b>20</b>. Administered as a single oral dose to tumor-bearing mice. Plasma samples were collected 6 h postdose and analyzed for drug exposure and PD biomarker modulation. Target inhibition was calculated relative to the average time-matched vehicle control. Error bars indicate ± standard error of the mean. Four mice were dosed for each compound and phosphoprotein levels were measured in duplicate samples for each mouse. (B) In vivo efficacy study with <b>20</b> in the MCF7neo/Her2 breast cancer model. LME = linear mixed effects model. The plot shows tumor volumes over time including a vehicle cohort. Vehicle = MCT = 0.5% methylcellulose/0.2% Tween-80; QD = every day.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, an effort to improve upon our lead THQ series by increasing cellular mTOR potency, reducing free drug clearance, attenuating CYP3A4 TDI, and maintaining a desirable solubility and absorption profile resulted in the discovery of the PATs. A newly developed synthetic methodology enabled access to an array of 6- and 7-N-substituted PATs that largely satisfied each of the above end points and led to the identification of inhibitor <b>20</b>. This molecule exhibited single-digit nanomolar mTOR cellular activity, excellent kinase selectivity, highly desirable free drug clearance, and excellent oral exposure in both mouse and dog. Furthermore, <b>20</b> displayed similar efficacy at less than half the dose of our current clinical candidate <b>1</b> in a 14-day tumor growth inhibition study. Thus, compound <b>20</b> is a novel, potent, and selective mTOR kinase inhibitor with PK properties consistent with a clinical candidate.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemicals were purchased from commercial suppliers and used as received. Flash chromatography was carried out with prepacked SiO<sub>2</sub> cartridges from either ISCO or SiliCycle on an ISCO Companion chromatography system using gradient elution. NMR spectra were recorded on a Bruker AV III 400 or 500 NMR spectrometer and referenced to tetramethylsilane. Preparative HPLC was performed on a Polaris C<sub>18</sub> 5 μm column (50 mm × 21 mm), eluting with mixtures of water–acetonitrile. Low-resolution mass spectra were recorded on a Sciex 15 mass spectrometer in ES+ mode. Diagnostic data are provided for intermediates that are mixtures of diastereomers. All final compounds were purified to >95% chemical and optical purity, as assayed by HPLC (Waters Acquity UPLC column, 21 mm × 50 mm, 1.7 μm) with a gradient of 0–90% acetonitrile (containing 0.038% TFA) in 0.1% aqueous TFA, with UV detection at λ = 254 and 210 as well as CAD detection with an ESA Corona detector. For chiral SFC conditions, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details of designated method.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Allyl 3-(<i>N</i>-(4-Methoxybenzyl)-4-nitrobenzamido)-8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate (<b>3</b>)</h3><div class="NLM_p last">Allyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate (<b>2</b>, 1.60 g, 7.65 mmol) and 4-methoxybenzylamine (0.999 mL, 7.65 mmol) were dissolved in methylene chloride (38 mL). Titanium(IV) ethoxide (7.93 mL, 38.2 mmol) was added, and the reaction mixture was heated to 40 °C in a sealed tube for 16 h. The reaction mixture was cooled to 0 °C, and to this was added triethylamine (1.97 mL, 14.1 mmol) and then 4-nitrobenzoyl chloride (1.56 g, 8.41 mmol). The reaction mixture was stirred at 0 °C for 10 min then warmed to room temperature. An additional 1.1 equiv of 4-nitrobenzoyl chloride (1.56 g, 8.41 mmol) was then added, and the reaction mixture was stirred at room temperature for an additional 2 h. A third portion of 4-nitrobenzoyl chloride (1.56 g, 8.41 mmol) was then added, and the reaction mixture was stirred at room temperature for an additional 30 min. The reaction mixture was then quenched with water and the turbid solution was filtered through Celite, eluting with DCM. The filtrate was separated, and the aqueous layer was extracted with DCM. The combined organic layers were then washed with saturated aqueous ammonium chloride, dried over sodium sulfate, and concentrated in vacuo. The crude residue was purified by flash column chromatography (50% EtOAc/heptane) to provide the title compound (3.05 g, 84% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.20 (d, <i>J</i> = 8.5 Hz, 2H), 7.65–7.56 (m, 2H), 7.25–7.21 (m, 2H), 6.86 (d, <i>J</i> = 8.4 Hz, 2H), 5.86–5.35 (m, 2H), 5.24–5.12 (m, 2H), 4.83–4.65 (m, 2H), 4.54–4.26 (m, 3H), 3.81 (s, 3H), 2.84–2.26 (m, 1H), 2.04–1.95 (m, 1H), 1.87–1.73 (m, 2H), 1.55–1.46 (m, 1H), 1.46–1.35 (m, 1H), 1.21–1.01 (m, 1H). LCMS, <i>m</i>/<i>z</i> = 478 [M + H]<sup>+</sup>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Allyl 4-((<i>S</i>)-3-Methylmorpholino)-2-(4-nitrophenyl)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidine-10-carboxylate (<b>4</b>)</h3><div class="NLM_p last">Trifluoromethanesulfonic anhydride (0.388 mL, 2.30 mmol) was added dropwise over 1 min to a stirred mixture of <b>3</b> (1.0 g, 2.1 mmol), (<i>S</i>)-3-methylmorpholine-4-carbonitrile (0.291 g, 2.30 mmol), and 2-chloropyridine (0.238 mL, 2.51 mmol) in methylene chloride (15 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 5 min and then warmed to 0 °C for 5 min and then warmed to room temperature and stirred for 3 h. The reaction mixture was diluted with DCM and quenched with 1 N NaOH<sub>(aq)</sub>. The aqueous layer was extracted with DCM (2×), and the combined organics were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by flash column chromatography (50% EtOAc/heptane) to provide the title compound (385 mg, 40% yield). LCMS, <i>m</i>/<i>z</i> = 466 [M + H]<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Allyl 2-(4-Aminophenyl)-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidine-10-carboxylate (<b>5</b>)</h3><div class="NLM_p last">To a mixture of <b>4</b> (270 mg, 0.58 mmol) in ethanol (7 mL) was added stannous chloride dihydrate (0.66 g, 2.9 mmol). The reaction mixture was heated to reflux for 2 h. The reaction mixture was then concentrated in vacuo and partitioned between 1 N NaOH<sub>(aq)</sub> and DCM. The layers were separated, and the organic layer was washed with 1 N NaOH<sub>(aq)</sub>. The combined aqueous layers were extracted with DCM and the combined organics were dried over sodium sulfate, filtered, and concentrated in vacuo to give the crude title compound which was used directly in the next step.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Allyl 2-(4-(3-Ethylureido)phenyl)-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidine-10-carboxylate (<b>6</b>)</h3><div class="NLM_p last">To a solution of crude <b>5</b> (250 mg, 0.58 mmol) and triethylamine (240 μL, 1.7 mmol) in 1,2-dichloroethane (5 mL) cooled to 0 °C was added triphosgene (68.5 mg, 0.231 mmol) in a single portion, and the mixture was stirred for 5 min at 0 °C. The reaction mixture was then heated to 70 °C for 40 min and then cooled to room temperature. Ethylamine hydrochloride (236 mg, 2.90 mmol) was added in a single portion, and the mixture was stirred overnight at room temperature. The reaction mixture was quenched by the addition of water and extracted with DCM (3×). The combined organics were dried over sodium sulfate and concentrated in vacuo to give the crude title compound which was used directly in the next step.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 1-Ethyl-3-(4-(4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>7</b>)</h3><div class="NLM_p last">To a solution of crude <b>6</b> (290 mg, 0.58 mmol) in tetrahydrofuran (3 mL) cooled to 0 °C was added tetrakis(triphenylphosphine)palladium(0) (67 mg, 0.058 mmol) and morpholine (2.5 mL, 29 mmol), and the reaction mixture was stirred at 0 °C for 15 min. The reaction mixture was diluted with 5% HCl<sub>(aq)</sub> and DCM. The layers were separated, and the aqueous layer was made basic by the addition of saturated aqueous sodium bicarbonate and extracted with DCM/MeOH (20:1) (4×). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to give the title compound which was used directly in the next step.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1-Ethyl-3-(4-((5<i>R</i>,8<i>S</i>)-10-methyl-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>8</b>) and 1-Ethyl-3-(4-((5<i>S</i>,8<i>R</i>)-10-methyl-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>9</b>)</h3><div class="NLM_p last">To a solution of crude <b>7</b> (75 mg, 0.18 mmol) in acetonitrile (1.8 mL) was added sodium cyanoborohydride (33 mg, 0.53 mmol) followed by aqueous formaldehyde (66 μL, 0.89 mmol) (37% w/w). The reaction mixture was stirred vigorously for 90 min. The reaction mixture was quenched by the addition of glacial acetic acid (100 μL) and concentrated in vacuo. The crude residue was purified by chiral SFC to give the title compounds as pure diastereomers. <b>8</b> (10.6 mg, 14% yield, five steps): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 8.61 (s, 1H), 8.15 (d, <i>J</i> = 8.7 Hz, 2H), 7.46 (d, <i>J</i> = 8.8 Hz, 2H), 6.16 (t, <i>J</i> = 5.7 Hz, 1H), 4.01–3.94 (m, 1H), 3.89–3.81 (m, 2H), 3.77–3.55 (m, 4H), 3.43–3.36 (m, 2H), 3.35–3.33 (m, 1H), 3.16–3.02 (m, 3H), 2.35–2.26 (m, 1H), 2.19 (s, 2H), 1.88–1.80 (m, 1H), 1.65–1.55 (m, 1H), 1.36 (d, <i>J</i> = 6.6 Hz, 3H), 1.06 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 437 [M + H]<sup>+</sup>. <b>9</b> (13.4 mg, 17% yield, five steps): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 8.63 (s, 1H), 8.16 (d, <i>J</i> = 8.7 Hz, 2H), 7.46 (d, <i>J</i> = 8.7 Hz, 2H), 6.15 (t, <i>J</i> = 5.5 Hz, 1H), 4.02–3.83 (m, 4H), 3.66–3.56 (m, 2H), 3.47–3.39 (m, 2H), 3.37–3.32 (m, 2H), 3.16–3.01 (m, 3H), 2.38–2.29 (m, 1H), 2.17 (s, 2H), 1.86–1.76 (m, 1H), 1.70–1.59 (m, 1H), 1.09–1.03 (m, 6H). LCMS, <i>m</i>/<i>z</i> = 437 [M + H]<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1-Ethyl-3-(4-((5<i>R</i>,8<i>S</i>)-10-ethyl-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>10</b>)</h3><div class="NLM_p last">To a solution of crude <b>7</b> (83 mg, 0.20 mmol) in acetonitrile (2.0 mL) was added sodium cyanoborohydride (37 mg, 0.59 mmol) followed by acetaldehyde (100 μL, 0.89 mmol). The reaction mixture was stirred vigorously for 90 min. An additional portion of acetaldehyde (100 μL, 0.89 mmol) was then added, and the reaction mixture was stirred for an additional 4 h. The reaction mixture was quenched by the addition of glacial acetic acid (100 μL) and concentrated in vacuo. The crude residue was purified by chiral SFC to give the title compound as a pure diastereomer (7.5 mg, 8% yield, five steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 8.6 Hz, 2H), 7.34 (d, <i>J</i> = 8.6 Hz, 2H), 6.20 (s, 1H), 4.64–4.58 (m, 1H), 4.09 (d, <i>J</i> = 5.8 Hz, 1H), 4.03–3.96 (m, 1H), 3.94–3.80 (m, 2H), 3.78–3.70 (m, 2H), 3.69–3.62 (m, 2H), 3.46–3.38 (m, 1H), 3.36–3.28 (m, 2H), 3.18 (dd, <i>J</i> = 18.5, 4.9 Hz, 1H), 2.59–2.34 (m, 4H), 2.31 (d, <i>J</i> = 8.9 Hz, 1H), 1.90 (t, <i>J</i> = 9.5 Hz, 1H), 1.74–1.65 (m, 1H), 1.46 (d, <i>J</i> = 6.6 Hz, 3H), 1.18 (t, <i>J</i> = 7.2 Hz, 3H), 1.11 (t, <i>J</i> = 7.1 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 451 [M + H]<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-Ethyl-3-(4-((5<i>R</i>,8<i>S</i>)-4-((<i>S</i>)-3-methylmorpholino)-10-(oxetan-3-yl)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>11</b>) and 1-Ethyl-3-(4-((5<i>S</i>,8<i>R</i>)-4-((<i>S</i>)-3-methylmorpholino)-10-(oxetan-3-yl)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>12</b>)</h3><div class="NLM_p last">To a solution of crude <b>7</b> (276 mg, 0.654 mmol) in 1,2-dichloroethane (5.2 mL) was added 3-oxetanone (240 mg, 3.3 mmol), and the reaction mixture was stirred under nitrogen for 10 min at 70 °C. Sodium triacetoxyborohydride (440 mg, 2.1 mmol) was then added, and the reaction mixture was stirred for 90 min. The reaction mixture was cooled to room temperature and quenched by the addition of water and then saturated aqueous sodium bicarbonate. The mixture was extracted with DCM (2×). The combined organic layers were dried over sodium sulfate and concentrated in vacuo. The crude residue was purified by flash column chromatography (0–80% EtOAc/heptane, then 0–10% MeOH/DCM) to provide the desired product which was further purified by chiral SFC to give the title compounds as pure diastereomers. <b>11</b> (11.4 mg, 4% yield, five steps): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 8.6 Hz, 2H), 7.36 (d, <i>J</i> = 8.6 Hz, 2H), 6.24 (s, 1H), 4.71 (t, <i>J</i> = 6.4 Hz, 1H), 4.65–4.52 (m, 4H), 3.98–3.88 (m, 3H), 3.84–3.77 (m, 1H), 3.77–3.61 (m, 4H), 3.60–3.55 (m, 1H), 3.40–3.28 (m, 3H), 3.10–3.02 (m, 1H), 2.59 (d, <i>J</i> = 18.4 Hz, 1H), 2.39–2.23 (m, 2H), 1.97–1.90 (m, 1H), 1.76–1.68 (m, 1H), 1.41 (d, <i>J</i> = 6.6 Hz, 3H), 1.21–1.16 (m, 3H). LCMS, <i>m</i>/<i>z</i> = 479 [M + H]<sup>+</sup>. <b>12</b> (10.3 mg, 3% yield, five steps): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.32 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (d, <i>J</i> = 8.7 Hz, 2H), 6.23 (s, 1H), 4.69 (t, <i>J</i> = 6.3 Hz, 1H), 4.62 (t, <i>J</i> = 5.9 Hz, 2H), 4.57–4.51 (m, 2H), 4.02 (d, <i>J</i> = 5.8 Hz, 1H), 3.98–3.89 (m, 3H), 3.74–3.63 (m, 3H), 3.59 (t, <i>J</i> = 6.0 Hz, 1H), 3.53–3.46 (m, 1H), 3.36–3.30 (m, 3H), 3.06 (dd, <i>J</i> = 18.4, 4.1 Hz, 1H), 2.62 (d, <i>J</i> = 18.4 Hz, 1H), 2.40–2.28 (m, 2H), 1.96–1.89 (m, 1H), 1.79–1.71 (m, 1H), 1.18 (t, <i>J</i> = 7.2 Hz, 3H), 1.14 (d, <i>J</i> = 6.6 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 479 [M + H]<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-Ethyl-3-(4-((5<i>R</i>,8<i>S</i>)-4-((<i>S</i>)-3-methylmorpholino)-10-(methylsulfonyl)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>13</b>)</h3><div class="NLM_p last">To a solution of crude <b>7</b> (87 mg, 0.20 mmol) in methylene chloride (1.2 mL) cooled to 0 °C were added <i>N</i>,<i>N</i>-diisopropylethylamine (110 μL, 0.62 mmol), 4-dimethylaminopyridine (2.5 mg, 0.020 mmol), and methanesulfonyl chloride (21 μL, 0.27 mmol). The reaction mixture was stirred for 30 min at 0 °C. The reaction mixture was quenched by the addition of water, extracted with DCM (2×), and the combined organic layers were dried over sodium sulfate and concentrated in vacuo. The crude residue was purified by preparative HPLC to give the title compound as a pure diastereomer (15.9 mg, 16% yield, five steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 8.6 Hz, 2H), 7.38 (d, <i>J</i> = 8.7 Hz, 2H), 6.29 (s, 1H), 5.11 (d, <i>J</i> = 5.5 Hz, 1H), 4.67–4.57 (m, 2H), 4.04–3.94 (m, 3H), 3.81–3.66 (m, 2H), 3.59–3.51 (m, 1H), 3.46–3.28 (m, 4H), 2.88 (d, <i>J</i> = 18.1 Hz, 1H), 2.83 (s, 3H), 2.52–2.39 (m, 2H), 2.12–2.03 (m, 1H), 1.93–1.84 (m, 1H), 1.23–1.15 (m, 6H). LCMS, <i>m</i>/<i>z</i> = 501 [M + H]<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-(4-((5<i>R</i>,8<i>S</i>)-10-Acetyl-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-5,8-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)-3-ethylurea (<b>14</b>)</h3><div class="NLM_p last">To a solution of crude <b>7</b> (102 mg, 0.241 mmol) and 4-dimethylaminopyridine (3.0 mg, 0.024 mmol) in methylene chloride (1.2 mL) cooled to 0 °C under nitrogen were added triethylamine (66 μL, 0.47 mmol) and acetic anhydride (33 μL, 0.36 mmol). The reaction mixture was stirred for 30 min at 0 °C. The reaction mixture was concentrated in vacuo and the crude residue was purified by preparative HPLC to give the title compound as a pure diastereomer (47.8 mg, 43% yield, five steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.29–8.12 (m, 2H), 7.34–7.20 (m, 2H), 6.70–6.52 (m, 1H), 5.60–4.96 (m, 2H), 4.94–4.79 (m, 1H), 4.56–4.49 (m, 1H), 4.08–3.90 (m, 3H), 3.82–3.63 (m, 2H), 3.54–3.38 (m, 2H), 3.38–3.27 (m, 3H), 2.92–2.71 (m, 1H), 2.50–2.25 (m, 2H), 2.17–1.80 (m, 5H), 1.26–1.12 (m, 5H). LCMS, <i>m</i>/<i>z</i> = 465 [M + H]<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-1-Ethyl-3-(4-(4-(3-methylmorpholino)-6-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[4,3-<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>15</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for previously reported 6-aza-tetrahydroquinazolines.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (s, 1H), 8.17 (d, <i>J</i> = 8.7 Hz, 2H), 7.47 (d, <i>J</i> = 8.8 Hz, 2H), 6.16 (t, <i>J</i> = 5.2 Hz, 1H), 4.63 (dd, <i>J</i> = 10.9, 6.2 Hz, 2H), 4.55–4.47 (m, 2H), 3.96–3.87 (m, 1H), 3.87–3.80 (m, 1H), 3.73–3.64 (m, 2H), 3.60 (t, <i>J</i> = 10.9 Hz, 2H), 3.50–3.36 (m, 3H), 3.25–3.20 (m, 1H), 3.16–3.08 (m, 2H), 2.96–2.81 (m, 2H), 2.77–2.69 (m, 1H), 2.64–2.56 (m, 1H), 1.20 (d, <i>J</i> = 6.6 Hz, 3H), 1.06 (t, <i>J</i> = 7.1 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 453 [M + H]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-Ethyl-3-(4-(4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>17</b>)</h3><div class="NLM_p last">See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for detailed experimental procedures for the preparation of compound <b>17</b>. The title compound was prepared in a manner analogous to that for <b>7</b> starting from 8-benzyl-8-azabicyclo[3.2.1]octan-2-one (<b>16</b>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<b>17</b>, 215 mg, 9% yield, six steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (d, <i>J</i> = 8.6 Hz, 2H), 7.35 (d, <i>J</i> = 8.6 Hz, 2H), 6.26 (s, 1H), 4.66 (t, <i>J</i> = 5.2 Hz, 1H), 4.32 (d, <i>J</i> = 5.5 Hz, 1H), 4.08–3.99 (m, 1H), 3.99–3.94 (m, 1H), 3.94–3.87 (m, 1H), 3.84–3.76 (m, 2H), 3.72 (dd, <i>J</i> = 11.3, 2.9 Hz, 1H), 3.64 (dd, <i>J</i> = 11.3, 2.2 Hz, 1H), 3.42–3.35 (m, 1H), 3.35–3.28 (m, 2H), 3.10 (dd, <i>J</i> = 16.2, 5.1 Hz, 1H), 2.29 (d, <i>J</i> = 16.1 Hz, 1H), 2.13–1.99 (m, 3H), 1.42 (d, <i>J</i> = 6.7 Hz, 3H), 1.17 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 423 [M + H]<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-Ethyl-3-(4-((6<i>S</i>,9<i>R</i>)-10-methyl-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>18</b>) and 1-Ethyl-3-(4-((6<i>R</i>,9<i>S</i>)-10-methyl-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>19</b>)</h3><div class="NLM_p last">To a mixture of <b>17</b> and the respective diastereomer (276 mg, 0.65 mmol) in acetonitrile (3.4 mL) was added sodium cyanoborohydride (208 mg, 0.28 mmol) followed by aqueous formaldehyde (73 μL, 0.98 mmol) (37% w/w). The reaction mixture was stirred vigorously for 5 min. Then the reaction mixture was diluted with water and EtOAc. The layers were separated, and the aqueous layer was extracted with DCM (2×). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by chiral SFC to give the title compounds as pure diastereomers. <b>18</b> (32.2 mg, 11% yield): <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (s, 1H), 8.16 (d, <i>J</i> = 8.8 Hz, 2H), 7.46 (d, <i>J</i> = 8.8 Hz, 2H), 6.14 (t, <i>J</i> = 5.5 Hz, 1H), 4.13–4.04 (m, 1H), 3.86–3.73 (m, 3H), 3.68–3.56 (m, 3H), 3.47–3.41 (m, 1H), 3.34–3.30 (m, 1H), 3.16–3.03 (m, 3H), 2.30 (s, 3H), 2.22–2.13 (m, 2H), 2.11–2.03 (m, 1H), 1.72–1.64 (m, 1H), 1.48–1.42 (m, 1H), 1.32 (d, <i>J</i> = 6.7 Hz, 3H), 1.06 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 437 [M + H]<sup>+</sup>. <b>19</b> (30.6 mg, 11% yield): <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (s, 1H), 8.16 (d, <i>J</i> = 8.8 Hz, 2H), 7.47 (d, <i>J</i> = 8.8 Hz, 2H), 6.13 (t, <i>J</i> = 5.7 Hz, 1H), 4.22–4.15 (m, 1H), 3.90–3.85 (m, 1H), 3.79–3.72 (m, 2H), 3.63–3.52 (m, 3H), 3.48–3.37 (m, 2H), 3.15–3.02 (m, 3H), 2.32 (s, 3H), 2.22–2.15 (m, 2H), 2.10–2.02 (m, 1H), 1.70–1.61 (m, 1H), 1.49–1.37 (m, 1H), 1.12 (d, <i>J</i> = 6.7 Hz, 3H), 1.06 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 437 [M + H]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-Ethyl-3-(4-((6<i>S</i>,9<i>R</i>)-4-((<i>S</i>)-3-methylmorpholino)-10-(oxetan-3-yl)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>20</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>11</b> to give the title compound as a pure diastereomer (48.2 mg, 18% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (s, 1H), 8.20–8.09 (m, 2H), 7.49–7.38 (m, 2H), 6.14 (t, <i>J</i> = 5.5 Hz, 1H), 4.65 (t, <i>J</i> = 6.3 Hz, 1H), 4.56 (t, <i>J</i> = 6.1 Hz, 1H), 4.46–4.37 (m, 2H), 4.13–4.07 (m, 1H), 3.88–3.75 (m, 4H), 3.69–3.57 (m, 3H), 3.55–3.50 (m, 1H), 3.34–3.30 (m, 1H), 3.17–3.08 (m, 2H), 3.00 (dd, <i>J</i> = 16.3, 4.9 Hz, 1H), 2.18 (d, <i>J</i> = 16.4 Hz, 1H), 2.15–2.08 (m, 1H), 2.07–1.98 (m, 1H), 1.76–1.67 (m, 1H), 1.48–1.40 (m, 1H), 1.34 (d, <i>J</i> = 6.7 Hz, 3H), 1.06 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 479 [M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-Ethyl-3-(4-((6<i>S</i>,9<i>R</i>)-4-((<i>S</i>)-3-methylmorpholino)-10-(methylsulfonyl)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>21</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>13</b> to give the title compound as a pure diastereomer (31.2 mg, 11% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (s, 1H), 8.17 (d, <i>J</i> = 8.8 Hz, 2H), 7.48 (d, <i>J</i> = 8.8 Hz, 2H), 6.19 (t, <i>J</i> = 5.6 Hz, 1H), 4.76 (d, <i>J</i> = 5.6 Hz, 1H), 4.57–4.47 (m, 1H), 4.16–4.07 (m, 1H), 3.91–3.81 (m, 2H), 3.70–3.58 (m, 3H), 3.26–3.23 (m, 1H), 3.17–3.08 (m, 2H), 3.06 (s, 3H), 2.34–2.14 (m, 2H), 1.89 (t, <i>J</i> = 9.8 Hz, 1H), 1.67–1.56 (m, 1H), 1.36 (d, <i>J</i> = 6.7 Hz, 3H), 1.06 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 501 [M + H]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-(4-((6<i>S</i>,9<i>R</i>)-10-Acetyl-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)-3-ethylurea (<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>14</b> to give the title compound as a pure diastereomer (43.9 mg, 17% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 8.6 Hz, 2H), 7.38 (d, <i>J</i> = 8.6 Hz, 2H), 6.28 (s, 1H), 5.04–4.98 (m, 1H), 4.88 (d, <i>J</i> = 6.0 Hz, 1H), 4.68–4.60 (m, 1H), 4.05–3.96 (m, 1H), 3.91 (d, <i>J</i> = 11.3 Hz, 2H), 3.86–3.69 (m, 1H), 3.69–3.63 (m, 2H), 3.43–3.28 (m, 4H), 2.34–1.98 (m, 7H), 1.51–1.42 (m, 4H), 1.19 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 465 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-Ethyl-3-(4-((6<i>S</i>,9<i>R</i>)-10-(2-methoxyacetyl)-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-2-yl)phenyl)urea (<b>23</b>)</h3><div class="NLM_p last">To a mixture of <b>17</b> and the respective diastereomer (236 mg, 0.558 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (4.15 mL) cooled to 0 °C were added <i>N</i>,<i>N</i>-diisopropylethylamine (0.39 mL, 2.23 mmol) and methoxyacetyl chloride (0.153 mL, 1.68 mmol). The reaction mixture was stirred at 0 °C for 30 min and then concentrated in vacuo. The crude residue was purified by chiral SFC to give the title compound as a pure diastereomer (51.2 mg, 19% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.41–8.26 (m, 2H), 7.56–7.35 (m, 2H), 6.45 (s, 1H), 5.64–4.98 (m, 2H), 4.80–4.67 (m, 1H), 4.24–3.86 (m, 5H), 3.85–3.69 (m, 2H), 3.66 (s, 2H), 3.50–3.26 (m, 7H), 2.49–1.95 (m, 4H), 1.50–1.41 (m, 3H), 1.18 (t, <i>J</i> = 7.2 Hz, 2H). LCMS, <i>m</i>/<i>z</i> = 495 [M + H]<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-((6<i>S</i>,9<i>R</i>)-2-(4-(3-Ethylureido)phenyl)-4-((<i>S</i>)-3-methylmorpholino)-6,7,8,9-tetrahydro-5<i>H</i>-6,9-epiminocyclohepta[<i>d</i>]pyrimidin-10-yl)-<i>N</i>,2-dimethylpropanamide (<b>24</b>)</h3><div class="NLM_p last">A mixture of <b>17</b> and the respective diastereomer (123 mg, 0.291 mmol), 2-bromo-<i>N</i>,2-dimethylpropanamide (105 mg, 0.581 mmol), and potassium carbonate (161 mg, 1.16 mmol) in acetonitrile (2.1 mL) was stirred in a pressure tube at 130 °C for 18 h and then cooled to room temperature and filtered through Celite, eluting with DCM. The filtrate was concentrated in vacuo and the crude residue was purified by preparative HPLC and then by chiral SFC to give the title compound as a pure diastereomer (8.8 mg, 6% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 8.7 Hz, 2H), 7.43–7.39 (m, 1H), 7.36 (d, <i>J</i> = 8.7 Hz, 2H), 6.30 (s, 1H), 4.68 (t, <i>J</i> = 5.3 Hz, 1H), 4.25 (d, <i>J</i> = 5.9 Hz, 1H), 4.12–4.02 (m, 1H), 3.96–3.89 (m, 1H), 3.84–3.65 (m, 5H), 3.44–3.28 (m, 3H), 3.04 (dd, <i>J</i> = 15.9, 4.7 Hz, 1H), 2.80 (d, <i>J</i> = 5.0 Hz, 3H), 2.33 (d, <i>J</i> = 15.6 Hz, 1H), 2.21–2.00 (m, 2H), 1.98–1.88 (m, 1H), 1.51–1.45 (m, 1H), 1.42 (d, <i>J</i> = 6.7 Hz, 3H), 1.37 (s, 3H), 1.27 (s, 3H), 1.18 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 522 [M + H]<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Molecular Modeling</h3><div class="NLM_p last">A homology model of the mTOR kinase domain was built from publicly available PI3Kγ crystal structures (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>) using the Fugue and Orchestrar modules of Sybyl, version 8.1 (Tripos Associates, St. Louis, MO), and further optimized using the Maximin module within Sybyl (all atoms, AmberFF02 charges on protein, MMFF94 charges on ligand) including the bound ligand from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>. Docking studies were conducted using Gold, version 4.1, with a single hydrogen bond constraint to the hinge Val backbone NH, allowing flexible Lys and Asp side chains so that the appropriate hydrogen bond geometry between the ligand urea moiety and protein could be attained. A 10 Å sphere around the centroid of the ligand was used to define the active site region.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/jm400194n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures (compound <b>17</b>) and X-ray ORTEP plot and data collection and analysis. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400194n/suppl_file/jm400194n_si_001.pdf">jm400194n_si_001.pdf (540.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400194n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony A. Estrada</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e481979096858085ca858a908c8b8a9da483818a81ca878b89"><span class="__cf_email__" data-cfemail="aecbdddadccfcacf80cfc0dac6c1c0d7eec9cbc0cb80cdc1c3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel G. Shore</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Blackwood</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yung-Hsiang Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gauri Deshmukh</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao Ding</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio G. DiPasquale</span> - <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer A. Epler</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori S. Friedman</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael F. T. Koehler</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lichuan Liu</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiva Malek</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Nonomiya</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel F. Ortwine</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhonghua Pei</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve Sideris</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederic St-Jean</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lan Trinh</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tom Truong</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Translational Oncology, §Biochemical and Cellular
Pharmacology, and ∥Drug Metabolism
and Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d482e2763-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Analytical, Bioanalytical, NMR, Pharmacokinetic, and Biopharmacology colleagues for their contributions. We also thank Marcia Belvin, Chris Hamman, Michael Hayes, Jane Kenny, Sophie Mukadam, Stephen Schmidt, Suzanne Tay, Ulka Vijapurkar, and Mengling Wong for their individual contributions.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">This paper posted ASAP on March 29, 2013 with missing data in Figure 7A. The revised version was reposted to the Web on April 2, 2013.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35"> Abbreviations Used</h2><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">methylcellulose/Tween</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">PAT</td><td class="NLM_def"><p class="first last">pyrimidoaminotropane</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time-dependent inhibition</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">THQ</td><td class="NLM_def"><p class="first last">tetrahydroquinazoline</p></td></tr><tr><td class="NLM_term">S6RP</td><td class="NLM_def"><p class="first last">S6 ribosomal protein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Don, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. F.</span><span> </span><span class="NLM_article-title">Recent clinical trials of mTOR-targeted cancer therapies</span> <span class="citation_source-journal">Rev. Recent Clin. Trials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.2174%2F157488711793980147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=20868343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A280%3ADC%252BC3M7hsFyrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=24-35&author=A.+S.+Donauthor=X.+F.+Zheng&title=Recent+clinical+trials+of+mTOR-targeted+cancer+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent clinical trials of mTOR-targeted cancer therapies</span></div><div class="casAuthors">Don Aruni S Arachchige; Zheng X F Steven</div><div class="citationInfo"><span class="NLM_cas:title">Reviews on recent clinical trials</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) is a central component within a complex intracellular signaling network that regulates various processes including cell growth, proliferation, metabolism, and angiogenesis.  A hyperactive PI3k/Akt/mTOR signaling pathway is found in many human cancers and alterations in this pathway is associated with the development and progression of cancer.  Drugs that target and inhibit mTOR activity are therefore expected to provide therapeutic value in a number of cancer types.  Several classes of mTOR-targeted therapeutics are currently being evaluated in cancer clinical trials, including the rapamycins, dual PI3K-mTOR inhibitors, and ATP-competitive mTORC1/2 inhibitors.  This review summarizes important findings from recently completed trials of mTOR inhibitors and also discusses preliminary data from ongoing trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRdTZMd7ktETToTC3aBaesfW6udTcc2ebSDZhpoKGGvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7hsFyrtg%253D%253D&md5=16a8a3d6b8778e70e7ed4eabd9dfcc76</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F157488711793980147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488711793980147%26sid%3Dliteratum%253Aachs%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DZheng%26aufirst%3DX.%2BF.%26atitle%3DRecent%2520clinical%2520trials%2520of%2520mTOR-targeted%2520cancer%2520therapies%26jtitle%3DRev.%2520Recent%2520Clin.%2520Trials%26date%3D2011%26volume%3D6%26spage%3D24%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahmoud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span> </span><span class="NLM_article-title">Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1056%2FNEJMoa1109653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=22149876" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2011&pages=520-529&author=J.+Baselgaauthor=M.+Camponeauthor=M.+Piccartauthor=H.+A.+Burrisauthor=H.+S.+Rugoauthor=T.+Sahmoudauthor=S.+Noguchiauthor=M.+Gnantauthor=K.+I.+Pritchardauthor=F.+Lebrunauthor=J.+T.+Beckauthor=Y.+Itoauthor=D.+Yardleyauthor=I.+Deleuauthor=A.+Perezauthor=T.+Bachelotauthor=L.+Vittoriauthor=Z.+Xuauthor=P.+Mukhopadhyayauthor=D.+Lebwohlauthor=G.+N.+Hortobagyi&title=Everolimus+in+postmenopausal+hormone-receptor-positive+advanced+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1109653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1109653%26sid%3Dliteratum%253Aachs%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DCampone%26aufirst%3DM.%26aulast%3DPiccart%26aufirst%3DM.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DSahmoud%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DS.%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLebrun%26aufirst%3DF.%26aulast%3DBeck%26aufirst%3DJ.%2BT.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DYardley%26aufirst%3DD.%26aulast%3DDeleu%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DBachelot%26aufirst%3DT.%26aulast%3DVittori%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26atitle%3DEverolimus%2520in%2520postmenopausal%2520hormone-receptor-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D366%26spage%3D520%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-competitive+mammalian+target+of+rapamycin+inhibitor+reveals+rapamycin-resistant+functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0ljIUXUgW2pD3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520reveals%2520rapamycin-resistant%2520functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e38&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-site+inhibitors+of+mTOR+target+rapamycin-resistant+outputs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-site%2520inhibitors%2520of%2520mTOR%2520target%2520rapamycin-resistant%2520outputs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3De38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Sun, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span> </span><span class="NLM_article-title">Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">7052</span><span class="NLM_x">–</span> <span class="NLM_lpage">7058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=7052-7058&author=S.+Y.+Sunauthor=L.+M.+Rosenbergauthor=X.+Wangauthor=Z.+Zhouauthor=P.+Yueauthor=H.+Fuauthor=F.+R.+Khuri&title=Activation+of+Akt+and+eIF4E+survival+pathways+by+rapamycin-mediated+mammalian+target+of+rapamycin+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DRosenberg%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26atitle%3DActivation%2520of%2520Akt%2520and%2520eIF4E%2520survival%2520pathways%2520by%2520rapamycin-mediated%2520mammalian%2520target%2520of%2520rapamycin%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D7052%26epage%3D7058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkavy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grohar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helman, L. J.</span><span> </span><span class="NLM_article-title">Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1932</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1932-1940&author=X.+Wanauthor=B.+Harkavyauthor=N.+Shenauthor=P.+Groharauthor=L.+J.+Helman&title=Rapamycin+induces+feedback+activation+of+Akt+signaling+through+an+IGF-1R-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DX.%26aulast%3DHarkavy%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DN.%26aulast%3DGrohar%26aufirst%3DP.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26atitle%3DRapamycin%2520induces%2520feedback%2520activation%2520of%2520Akt%2520signaling%2520through%2520an%2520IGF-1R-dependent%2520mechanism%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1932%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.-G.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+cellular%2C+and+in+vivo+activity+of+novel+ATP-competitive+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%252C%2520and%2520in%2520vivo%2520activity%2520of%2520novel%2520ATP-competitive%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7942</span><span class="NLM_x">–</span> <span class="NLM_lpage">7945</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901415x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7942-7945&author=A.+Zaskauthor=J.+Kaplanauthor=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=N.+Brooijmansauthor=E.+M.+Bennettauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=K.+Yu&title=Morpholine+derivatives+greatly+enhance+the+selectivity+of+mammalian+target+of+rapamycin+%28mTOR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors</span></div><div class="casAuthors">Zask, Arie; Kaplan, Joshua; Verheijen, Jeroen C.; Richard, David J.; Curran, Kevin; Brooijmans, Natasja; Bennett, Eric M.; Toral-Barza, Lourdes; Hollander, Irwin; Ayral-Kaloustian, Semiramis; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7942-7945</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dramatic improvements in mTOR-targeting selectivity were achieved by replacing morpholine in pyrazolopyrimidine inhibitors with bridged morpholines.  Analogs I [R1 = (R)- or (S)-3-methyl-4-morpholinyl, 2-methyl-4-morpholinyl, 8-oxa-3-azabicyclo[3.2.1]octan-3-yl, etc.; R2 = Me, Et, cyclopropyl, FCH2CH2, 3-pyridyl, 4-pyridyl; R3 = F3CCH2, 1-methoxycarbonyl-4-piperidinyl, 1-ethoxycarbonyl-4-piperidinyl, 3-pyridylmethyl] with subnanomolar mTOR IC50 values and up to 26000-fold selectivity vs. PI3Kα were prepd.  Chiral morpholines gave inhibitors whose enantiomers had different selectivity and potency profiles.  Mol. modeling suggests that a single amino acid difference between PI3K and mTOR (Phe961Leu) accounts for the profound selectivity seen by creating a deeper pocket in mTOR that can accommodate bridged morpholines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2HnMHqTHqbVg90H21EOLACvtfcHk0lhd6fpIrA6Ysg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J&md5=5ef1eee5aa79531970049d3d26b46eb2</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm901415x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901415x%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DMorpholine%2520derivatives%2520greatly%2520enhance%2520the%2520selectivity%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7942%26epage%3D7945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">García Martínez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garc%C3%ADa+Mart%C3%ADnezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%2BMart%25C3%25ADnez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span> </span><span class="NLM_article-title">Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.-L.+Cockcroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+L.+Gallauthor=G.+Hermann&title=Identification+and+optimisation+of+novel+and+selective+small+molecular+weight+kinase+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockcroft%26aufirst%3DX.-L.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DGall%26aufirst%3DA.%2BL.%26aulast%3DHermann%26aufirst%3DG.%26atitle%3DIdentification%2520and%2520optimisation%2520of%2520novel%2520and%2520selective%2520small%2520molecular%2520weight%2520kinase%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span> </span><span class="NLM_article-title">The discovery and optimisation of pyrido[2,3-<i>d</i>]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5950</span><span class="NLM_x">–</span> <span class="NLM_lpage">5953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5950-5953&author=K.+Malaguauthor=H.+Dugganauthor=K.+Menearauthor=M.+Hummersoneauthor=S.+Gomezauthor=C.+Baileyauthor=P.+Edwardsauthor=J.+Drzewieckiauthor=F.+Lerouxauthor=M.+J.+Quesada&title=The+discovery+and+optimisation+of+pyrido%5B2%2C3-d%5Dpyrimidine-2%2C4-diamines+as+potent+and+selective+inhibitors+of+mTOR+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DDuggan%26aufirst%3DH.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520discovery%2520and%2520optimisation%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidine-2%252C4-diamines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mTOR%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5950%26epage%3D5953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7081</span><span class="NLM_x">–</span> <span class="NLM_lpage">7089</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012642" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7081-7089&author=P.+Nowakauthor=D.+C.+Coleauthor=N.+Brooijmansauthor=M.+G.+Bursavichauthor=K.+J.+Curranauthor=J.+W.+Ellingboeauthor=J.+J.+Gibbonsauthor=I.+Hollanderauthor=Y.+Huauthor=J.+Kaplanauthor=D.+J.+Malwitzauthor=L.+Toral-Barzaauthor=J.+C.+Verheijenauthor=A.+Zaskauthor=W.-G.+Zhangauthor=K.+Yu&title=Discovery+of+potent+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1021%2Fjm9012642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012642%26sid%3Dliteratum%253Aachs%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7081%26epage%3D7089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 2-arylthieno[3.2-<i>d</i>]pyrimidines containing 8-oxa-3-azabicyclo[3.2.1]octane in the 4-position as potent inhibitors of mTOR with selectivity over PI3K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=375-379&author=J.+C.+Verheijenauthor=K.+Yuauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=A.+Zask&title=Discovery+of+2-arylthieno%5B3.2-d%5Dpyrimidines+containing+8-oxa-3-azabicyclo%5B3.2.1%5Doctane+in+the+4-position+as+potent+inhibitors+of+mTOR+with+selectivity+over+PI3K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25202-arylthieno%255B3.2-d%255Dpyrimidines%2520containing%25208-oxa-3-azabicyclo%255B3.2.1%255Doctane%2520in%2520the%25204-position%2520as%2520potent%2520inhibitors%2520of%2520mTOR%2520with%2520selectivity%2520over%2520PI3K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D375%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=288-298&author=C.+M.+Chrestaauthor=B.+R.+Daviesauthor=I.+Hicksonauthor=T.+Hardingauthor=S.+Cosulichauthor=S.+E.+Critchlowauthor=J.+P.+Vincentauthor=R.+Ellstonauthor=D.+Jonesauthor=P.+Siniauthor=D.+Jamesauthor=Z.+Howardauthor=P.+Dudleyauthor=G.+Hughesauthor=L.+Smithauthor=S.+Maguireauthor=M.+Hummersoneauthor=K.+Malaguauthor=K.+Menearauthor=R.+Jenkinsauthor=M.+Jacobsenauthor=G.+C.+M.+Smithauthor=S.+Guichardauthor=M.+Pass&title=AZD8055+is+a+potent%2C+selective%2C+and+orally+bioavailable+ATP-competitive+mammalian+target+of+rapamycin+kinase+inhibitor+with+in+vitro+and+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHarding%26aufirst%3DT.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DEllston%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DZ.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DJenkins%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DAZD8055%2520is%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520kinase%2520inhibitor%2520with%2520in%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D288%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markhard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[<i>h</i>][1,6]naphthyridin-2(1<i>H</i>)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7146</span><span class="NLM_x">–</span> <span class="NLM_lpage">7155</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101144f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7146-7155&author=Q.+Liuauthor=J.+W.+Changauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=A.+Markhardauthor=W.+Hurauthor=J.+Zhangauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+1-%284-%284-propionylpiperazin-1-yl%29-3-%28trifluoromethyl%29phenyl%29-9-%28quinolin-3-yl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+as+a+highly+potent%2C+selective+mammalian+target+of+rapamycin+%28mTOR%29+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8j&amp;dbid=16384&amp;doi=10.1021%2Fjm101144f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101144f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DMarkhard%26aufirst%3DA.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25201-%25284-%25284-propionylpiperazin-1-yl%2529-3-%2528trifluoromethyl%2529phenyl%2529-9-%2528quinolin-3-yl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520as%2520a%2520highly%2520potent%252C%2520selective%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7146%26epage%3D7155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 3,6-dihydro-2<i>H</i>-pyran as a morpholine replacement in 6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines and 2-arylthieno[3,2-<i>d</i>]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2009.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=19963384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=640-643&author=J.+Kaplanauthor=J.+C.+Verheijenauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+3%2C6-dihydro-2H-pyran+as+a+morpholine+replacement+in+6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+and+2-arylthieno%5B3%2C2-d%5Dpyrimidines%3A+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8kR"><div class="casContent"><span class="casTitleNuber">8k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span></div><div class="casAuthors">Kaplan, Joshua; Verheijen, Jeroen C.; Brooijmans, Natasja; Toral-Barza, Lourdes; Hollander, Irwin; Yu, Ker; Zask, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">640-643</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The morpholine hinge-region binding group on a series of pyrazolopyrimidine and thienopyrimidine mammalian target of rapamycin (mTOR) inhibitors was replaced with 3,6-dihydro-2H-pyran (DHP), giving compds. of equiv. potency and selectivity vs. PI3K.  These results establish the DHP group as a hinge-region binding motif for the prepn. of highly potent and selective mTOR inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBTLsFT9FBubVg90H21EOLACvtfcHk0ljJMcUofVkVeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE&md5=9398107e05207e302a8358103f31fb2f</span></div><a href="/servlet/linkout?suffix=cit8k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25203%252C6-dihydro-2H-pyran%2520as%2520a%2520morpholine%2520replacement%2520in%25206-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520and%25202-arylthieno%255B3%252C2-d%255Dpyrimidines%253A%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D640%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Curran, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 1-substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1440-1444&author=K.+J.+Curranauthor=J.+C.+Verheijenauthor=J.+Kaplanauthor=D.+J.+Richardauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=J.+Lucasauthor=S.+Ayral-Kaloustianauthor=K.+Yuauthor=A.+Zask&title=Pyrazolopyrimidines+as+highly+potent+and+selective%2C+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29%3A+optimization+of+the+1-substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DPyrazolopyrimidines%2520as%2520highly%2520potent%2520and%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%253A%2520optimization%2520of%2520the%25201-substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1440%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">4-Substituted-7-azaindoles bearing a ureidobenzofuranone moiety as potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2259-2263&author=H.-R.+Tsouauthor=G.+MacEwanauthor=G.+Birnbergauthor=N.+Zhangauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=K.+Yu&title=4-Substituted-7-azaindoles+bearing+a+ureidobenzofuranone+moiety+as+potent+and+selective%2C+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3D4-Substituted-7-azaindoles%2520bearing%2520a%2520ureidobenzofuranone%2520moiety%2520as%2520potent%2520and%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2259%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2644</span><span class="NLM_x">–</span> <span class="NLM_lpage">2647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8n&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2010.02.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8n&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=20227881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8n&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVGntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2644-2647&author=A.+Zaskauthor=J.+C.+Verheijenauthor=D.+J.+Richardauthor=J.+Kaplanauthor=K.+Curranauthor=L.+Toral-Barzaauthor=J.+Lucasauthor=I.+Hollanderauthor=K.+Yu&title=Discovery+of+2-ureidophenyltriazines+bearing+bridged+morpholines+as+potent+and+selective+ATP-competitive+mTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8nR"><div class="casContent"><span class="casTitleNuber">8n</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors</span></div><div class="casAuthors">Zask, Arie; Verheijen, Jeroen C.; Richard, David J.; Kaplan, Joshua; Curran, Kevin; Toral-Barza, Lourdes; Lucas, Judy; Hollander, Irwin; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2644-2647</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Incorporation of bridged morpholines in monocyclic triazine PI3K/mTOR inhibitors gave compds. with increased mTOR selectivity relative to the corresponding morpholine analogs.  Compds. with ureidophenyl groups gave highly potent and selective mTOR inhibitors.  Potency and selectivity was demonstrated both in vitro and in vivo through biomarker suppression studies.  Select compds. exhibited potent inhibition of tumor growth in nude mouse xenograft assays upon PO and IV administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUPE--c1OgzbVg90H21EOLACvtfcHk0li3SuVbpGWtHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVGntro%253D&md5=d5008526e962f9dd110bfb47306c551e</span></div><a href="/servlet/linkout?suffix=cit8n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.045%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDiscovery%2520of%25202-ureidophenyltriazines%2520bearing%2520bridged%2520morpholines%2520as%2520potent%2520and%2520selective%2520ATP-competitive%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2644%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Triazines incorporating (<i>R</i>)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kalpha</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2654</span><span class="NLM_x">–</span> <span class="NLM_lpage">2657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2654-2657&author=D.+J.+Richardauthor=J.+C.+Verheijenauthor=K.+Yuauthor=A.+Zask&title=Triazines+incorporating+%28R%29-3-methylmorpholine+are+potent+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29+with+selectivity+over+PI3Kalpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DTriazines%2520incorporating%2520%2528R%2529-3-methylmorpholine%2520are%2520potent%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520with%2520selectivity%2520over%2520PI3Kalpha%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2654%26epage%3D2657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Peterson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Be, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubinska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span> </span><span class="NLM_article-title">Discovery of triazine-benzimidazoles as selective inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2064</span><span class="NLM_x">–</span> <span class="NLM_lpage">2070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2064-2070&author=E.+A.+Petersonauthor=P.+S.+Andrewsauthor=X.+Beauthor=A.+A.+Boezioauthor=T.+L.+Bushauthor=A.+C.+Chengauthor=J.+R.+Coatsauthor=A.+E.+Collettiauthor=K.+W.+Copelandauthor=M.+DuPontauthor=R.+Graceffaauthor=B.+Grubinskaauthor=J.-C.+Harmangeauthor=J.+L.+Kimauthor=E.+L.+Mulladyauthor=P.+Olivieriauthor=L.+B.+Schenkelauthor=M.+K.+Stantonauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=T.+Caiauthor=D.+S.+La&title=Discovery+of+triazine-benzimidazoles+as+selective+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DBe%26aufirst%3DX.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBush%26aufirst%3DT.%2BL.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCoats%26aufirst%3DJ.%2BR.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DDuPont%26aufirst%3DM.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGrubinska%26aufirst%3DB.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DStanton%26aufirst%3DM.%2BK.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DLa%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520of%2520triazine-benzimidazoles%2520as%2520selective%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2064%26epage%3D2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4036</span><span class="NLM_x">–</span> <span class="NLM_lpage">4040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4036-4040&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=H.+G.+Choiauthor=D.+L.+Wallerauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+and+optimization+of+potent+and+selective+benzonaphthyridinone+analogs+as+small+molecule+mTOR+inhibitors+with+improved+mouse+microsome+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DWaller%26aufirst%3DD.%2BL.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520and%2520selective%2520benzonaphthyridinone%2520analogs%2520as%2520small%2520molecule%2520mTOR%2520inhibitors%2520with%2520improved%2520mouse%2520microsome%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4036%26epage%3D4040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[<i>h</i>][1,6]naphthyridin-2(1<i>H</i>)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1473</span><span class="NLM_x">–</span> <span class="NLM_lpage">1480</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+potent%2C+selective%2C+and+orally+available+mammalian+target+of+rapamycin+%28mTOR%29+inhibitor+for+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8r&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coate, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares-Greco, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-<i>a</i>]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2092</span><span class="NLM_x">–</span> <span class="NLM_lpage">2097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2092-2097&author=A.+P.+Crewauthor=S.+V.+Bhagwatauthor=H.+Dongauthor=M.+A.+Bittnerauthor=A.+Chanauthor=X.+Chenauthor=H.+Coateauthor=A.+Cookeauthor=P.+C.+Gokhaleauthor=A.+Hondaauthor=M.+Jinauthor=J.+Kahlerauthor=C.+Mantisauthor=M.+J.+Mulvihillauthor=P.+A.+Tavares-Grecoauthor=B.+Volkauthor=J.+Wangauthor=D.+S.+Wernerauthor=L.+D.+Arnoldauthor=J.+A.+Pachterauthor=R.+Wildauthor=N.+W.+Gibson&title=Imidazo%5B1%2C5-a%5Dpyrazines%3A+orally+efficacious+inhibitors+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DBhagwat%26aufirst%3DS.%2BV.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DBittner%26aufirst%3DM.%2BA.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCoate%26aufirst%3DH.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DGokhale%26aufirst%3DP.%2BC.%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DMantis%26aufirst%3DC.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DTavares-Greco%26aufirst%3DP.%2BA.%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWerner%26aufirst%3DD.%2BS.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26aulast%3DWild%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26atitle%3DImidazo%255B1%252C5-a%255Dpyrazines%253A%2520orally%2520efficacious%2520inhibitors%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2092%26epage%3D2097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Bhagwat, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudkin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8t&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1158%2F1535-7163.MCT-10-1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8t&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=21673091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8t&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1394-1406&author=S.+V.+Bhagwatauthor=P.+C.+Gokhaleauthor=A.+P.+Crewauthor=A.+Cookeauthor=Y.+Yaoauthor=C.+Mantisauthor=J.+Kahlerauthor=J.+Workmanauthor=M.+Bittnerauthor=L.+Dudkinauthor=D.+M.+Epsteinauthor=N.+W.+Gibsonauthor=R.+Wildauthor=L.+D.+Arnoldauthor=P.+J.+Houghtonauthor=J.+A.+Pachter&title=Preclinical+characterization+of+OSI-027%2C+a+potent+and+selective+inhibitor+of+mTORC1+and+mTORC2%3A+distinct+from+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8tR"><div class="casContent"><span class="casTitleNuber">8t</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin</span></div><div class="casAuthors">Bhagwat, Shripad V.; Gokhale, Prafulla C.; Crew, Andrew P.; Cooke, Andy; Yao, Yan; Mantis, Christine; Kahler, Jennifer; Workman, Jennifer; Bittner, Mark; Dudkin, Lorina; Epstein, David M.; Gibson, Neil W.; Wild, Robert; Arnold, Lee D.; Houghton, Peter J.; Pachter, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1394-1406</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway is frequently activated in human cancers, and mTOR is a clin. validated target.  MTOR forms two distinct multiprotein complexes, mTORC1 and mTORC2, which regulate cell growth, metab., proliferation, and survival.  Rapamycin and its analogs partially inhibit mTOR through allosteric binding to mTORC1, but not mTORC2, and have shown clin. utility in certain cancers.  Here, we report the preclin. characterization of OSI-027, a selective and potent dual inhibitor of mTORC1 and mTORC2 with biochem. IC50 values of 22 nmol/L and 65 nmol/L, resp.  OSI-027 shows more than 100-fold selectivity for mTOR relative to PI3Kα, PI3Kβ, PI3Kγ, and DNA-PK.  OSI-027 inhibits phosphorylation of the mTORC1 substrates 4E-BP1 and S6K1 as well as the mTORC2 substrate AKT in diverse cancer models in vitro and in vivo.  OSI-027 and OXA-01 (close analog of OSI-027) potently inhibit proliferation of several rapamycin-sensitive and -insensitive nonengineered and engineered cancer cell lines and also, induce cell death in tumor cell lines with activated PI3K-AKT signaling.  OSI-027 shows concn.-dependent pharmacodynamic effects on phosphorylation of 4E-BP1 and AKT in tumor tissue with resulting tumor growth inhibition.  OSI-027 shows robust antitumor activity in several different human xenograft models representing various histologies.  Furthermore, in COLO 205 and GEO colon cancer xenograft models, OSI-027 shows superior efficacy compared with rapamycin.  Our results further support the important role of mTOR as a driver of tumor growth and establish OSI-027 as a potent anticancer agent.  OSI-027 is currently in phase I clin. trials in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLyA6Bn0nZqbVg90H21EOLACvtfcHk0lj3Yh0NaPWsAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLnF&md5=8d91103e12ab5c632571f17510b3ee7f</span></div><a href="/servlet/linkout?suffix=cit8t&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-1099%26sid%3Dliteratum%253Aachs%26aulast%3DBhagwat%26aufirst%3DS.%2BV.%26aulast%3DGokhale%26aufirst%3DP.%2BC.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DMantis%26aufirst%3DC.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DWorkman%26aufirst%3DJ.%26aulast%3DBittner%26aufirst%3DM.%26aulast%3DDudkin%26aufirst%3DL.%26aulast%3DEpstein%26aufirst%3DD.%2BM.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DWild%26aufirst%3DR.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520OSI-027%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%253A%2520distinct%2520from%2520rapamycin%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1394%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Mortensen, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin-Ninkovic, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevlin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khambatta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisonette, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fultz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankar, S.</span><span> </span><span class="NLM_article-title">Discovery and SAR exploration of a novel series of imidazo[4,5-<i>b</i>]pyrazin-2-ones as potent and selective mTOR kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6793</span><span class="NLM_x">–</span> <span class="NLM_lpage">6799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8u&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2011.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8u&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=21978683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8u&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6793-6799&author=D.+S.+Mortensenauthor=S.+M.+Perrin-Ninkovicauthor=R.+Harrisauthor=B.+G.+S.+Leeauthor=G.+Shevlinauthor=M.+Hickmanauthor=G.+Khambattaauthor=R.+R.+Bisonetteauthor=K.+E.+Fultzauthor=S.+Sankar&title=Discovery+and+SAR+exploration+of+a+novel+series+of+imidazo%5B4%2C5-b%5Dpyrazin-2-ones+as+potent+and+selective+mTOR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8uR"><div class="casContent"><span class="casTitleNuber">8u</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Mortensen, Deborah S.; Perrin-Ninkovic, Sophie M.; Harris, Roy; Lee, Branden G. S.; Shevlin, Graziella; Hickman, Matt; Khambatta, Gody; Bisonette, Rene R.; Fultz, Kimberly E.; Sankar, Sabita</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6793-6799</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report here the discovery of a novel series of selective mTOR kinase inhibitors.  A series of imidazo[4,5-b]pyrazin-2-ones, represented by screening hit 1, was developed into lead compds. with excellent mTOR potency and exquisite kinase selectivity.  Potent compds. from this series show >1000-fold selectivity over the related PI3Kα lipid kinase.  Further, compds. such as 2 achieve mTOR pathway inhibition, blocking both mTORC1 and mTORC2 signaling, in PC3 cancer cells as measured by inhibition of pS6 and pAkt (S473).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWly4sBJXgerVg90H21EOLACvtfcHk0lj3Yh0NaPWsAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P&md5=d422a7d505c1032951547d997ac2e033</span></div><a href="/servlet/linkout?suffix=cit8u&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DD.%2BS.%26aulast%3DPerrin-Ninkovic%26aufirst%3DS.%2BM.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DB.%2BG.%2BS.%26aulast%3DShevlin%26aufirst%3DG.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DKhambatta%26aufirst%3DG.%26aulast%3DBisonette%26aufirst%3DR.%2BR.%26aulast%3DFultz%26aufirst%3DK.%2BE.%26aulast%3DSankar%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520SAR%2520exploration%2520of%2520a%2520novel%2520series%2520of%2520imidazo%255B4%252C5-b%255Dpyrazin-2-ones%2520as%2520potent%2520and%2520selective%2520mTOR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6793%26epage%3D6799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dishington, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillery, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glossop, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, A. M.</span><span> </span><span class="NLM_article-title">Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4163</span><span class="NLM_x">–</span> <span class="NLM_lpage">4168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4163-4168&author=M.+R.+V.+Finlayauthor=D.+Buttarauthor=S.+E.+Critchlowauthor=A.+P.+Dishingtonauthor=S.+M.+Filleryauthor=E.+Fisherauthor=S.+C.+Glossopauthor=M.+A.+Grahamauthor=T.+Johnsonauthor=G.+M.+Lamontauthor=S.+Muttonauthor=P.+Perkinsauthor=K.+G.+Pikeauthor=A.+M.+Slater&title=Sulfonyl-morpholino-pyrimidines%3A+SAR+and+development+of+a+novel+class+of+selective+mTOR+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8v&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DButtar%26aufirst%3DD.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DDishington%26aufirst%3DA.%2BP.%26aulast%3DFillery%26aufirst%3DS.%2BM.%26aulast%3DFisher%26aufirst%3DE.%26aulast%3DGlossop%26aufirst%3DS.%2BC.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DG.%2BM.%26aulast%3DMutton%26aufirst%3DS.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DSlater%26aufirst%3DA.%2BM.%26atitle%3DSulfonyl-morpholino-pyrimidines%253A%2520SAR%2520and%2520development%2520of%2520a%2520novel%2520class%2520of%2520selective%2520mTOR%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4163%26epage%3D4168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Peterson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubinska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellwagen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4967</span><span class="NLM_x">–</span> <span class="NLM_lpage">4974</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4967-4974&author=E.+A.+Petersonauthor=A.+A.+Boezioauthor=P.+S.+Andrewsauthor=C.+M.+Boezioauthor=T.+L.+Bushauthor=A.+C.+Chengauthor=D.+Choquetteauthor=J.+R.+Coatsauthor=A.+E.+Collettiauthor=K.+W.+Copelandauthor=M.+DuPontauthor=R.+Graceffaauthor=B.+Grubinskaauthor=J.+L.+Kimauthor=R.+T.+Lewisauthor=J.+Liuauthor=E.+L.+Mulladyauthor=M.+H.+Potashmanauthor=K.+Romeroauthor=P.+L.+Shafferauthor=M.+K.+Stantonauthor=J.+C.+Stellwagenauthor=Y.+Tefferaauthor=S.+Yiauthor=T.+Caiauthor=D.+S.+La&title=Discovery+and+optimization+of+potent+and+selective+imidazopyridine+and+imidazopyridazine+mTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8w&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DBoezio%26aufirst%3DC.%2BM.%26aulast%3DBush%26aufirst%3DT.%2BL.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoats%26aufirst%3DJ.%2BR.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DDuPont%26aufirst%3DM.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGrubinska%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DRomero%26aufirst%3DK.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26aulast%3DStanton%26aufirst%3DM.%2BK.%26aulast%3DStellwagen%26aufirst%3DJ.%2BC.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DLa%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520and%2520selective%2520imidazopyridine%2520and%2520imidazopyridazine%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4967%26epage%3D4974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Liu, K. K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span> </span><span class="NLM_article-title">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5114</span><span class="NLM_x">–</span> <span class="NLM_lpage">5117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8x&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2012.05.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8x&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=22765900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8x&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5114-5117&author=K.+K.+C.+Liuauthor=S.+Baileyauthor=D.+M.+Dinhauthor=H.+Lamauthor=C.+Liauthor=P.+A.+Wellsauthor=M.-J.+Yinauthor=A.+Zou&title=Conformationally-restricted+cyclic+sulfones+as+potent+and+selective+mTOR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8xR"><div class="casContent"><span class="casTitleNuber">8x</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Liu, Kevin K.-C.; Bailey, Simon; Dinh, Dac M.; Lam, Hieu; Li, Chunze; Wells, Peter A.; Yin, Min-Jean; Zou, Aihua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5114-5117</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel conformationally-restricted mTOR kinase inhibitors with cyclic sulfone scaffold were designed.  Synthesis and structure-activity relationship (SAR) studies are described with emphasis on optimization of the mTOR potency and selectivity against class I PI3Kα kinase.  PF-05139962 I was identified with excellent mTOR biochem. inhibition, cellular potency, kinase selectivity and in vitro ADME properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmuwjN05w_4LVg90H21EOLACvtfcHk0lgjmk2W5CrcTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D&md5=c1abe951c4d17f22a2301004eff55d91</span></div><a href="/servlet/linkout?suffix=cit8x&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.104%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.%2BC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DZou%26aufirst%3DA.%26atitle%3DConformationally-restricted%2520cyclic%2520sulfones%2520as%2520potent%2520and%2520selective%2520mTOR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5114%26epage%3D5117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3426</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200215y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3426-3435&author=F.+Cohenauthor=P.+Bergeronauthor=E.+Blackwoodauthor=K.+K.+Bowmanauthor=H.+Chenauthor=A.+G.+DiPasqualeauthor=J.+A.+Eplerauthor=M.+F.+T.+Koehlerauthor=K.+Lauauthor=C.+Lewisauthor=L.+Liuauthor=C.+Q.+Lyauthor=S.+Malekauthor=J.+Nonomiyaauthor=D.+F.+Ortwineauthor=Z.+Peiauthor=K.+D.+Robargeauthor=S.+Siderisauthor=L.+Trinhauthor=T.+Truongauthor=J.+Wuauthor=X.+Zhaoauthor=J.+P.+Lyssikatos&title=Potent%2C+selective%2C+and+orally+bioavailable+inhibitors+of+mammalian+target+of+rapamycin+%28mTOR%29+kinase+based+on+a+quaternary+substituted+dihydrofuropyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm200215y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200215y%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DEpler%26aufirst%3DJ.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DRobarge%26aufirst%3DK.%2BD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DPotent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%2520based%2520on%2520a%2520quaternary%2520substituted%2520dihydrofuropyrimidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3426%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Potent, selective and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase domain exhibiting single agent antiproliferative activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10958</span><span class="NLM_x">–</span> <span class="NLM_lpage">10971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301389h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10958-10971&author=M.+F.+T.+Koehlerauthor=P.+Bergeronauthor=E.+Blackwoodauthor=K.+K.+Bowmanauthor=Y.-H.+Chenauthor=G.+Deshmukhauthor=X.+Dingauthor=J.+Eplerauthor=K.+Lauauthor=L.+Leeauthor=L.+Liuauthor=C.+Lyauthor=S.+Malekauthor=J.+Nonomiyaauthor=J.+Oehauthor=D.+F.+Ortwineauthor=D.+Sampathauthor=S.+Siderisauthor=L.+Trinhauthor=T.+Truongauthor=J.+Wuauthor=Z.+Peiauthor=J.+P.+Lyssikatos&title=Potent%2C+selective+and+orally+bioavailable+inhibitors+of+mammalian+target+of+rapamycin+%28mTOR%29+kinase+domain+exhibiting+single+agent+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm301389h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301389h%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DY.-H.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DEpler%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLy%26aufirst%3DC.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOeh%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DPotent%252C%2520selective%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%2520domain%2520exhibiting%2520single%2520agent%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10958%26epage%3D10971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijapurkar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Discovery and biological profiling of potent and selective mTOR inhibitor GDC-0349</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3003132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=103-107&author=Z.+Peiauthor=E.+Blackwoodauthor=L.+Liuauthor=S.+Malekauthor=M.+Belvinauthor=M.+F.+T.+Koehlerauthor=D.+F.+Ortwineauthor=H.+Chenauthor=F.+Cohenauthor=J.+R.+Kennyauthor=P.+Bergeronauthor=K.+Lauauthor=C.+Lyauthor=X.+Zhaoauthor=A.+A.+Estradaauthor=T.+Truongauthor=J.+A.+Eplerauthor=J.+Nonomiyaauthor=L.+Trinhauthor=S.+Siderisauthor=J.+Lesnickauthor=L.+Baoauthor=U.+Vijapurkarauthor=S.+Mukadamauthor=S.+Tayauthor=G.+Deshmukhauthor=Y.-H.+Chenauthor=X.+Dingauthor=L.+Friedmanauthor=J.+P.+Lyssikatos&title=Discovery+and+biological+profiling+of+potent+and+selective+mTOR+inhibitor+GDC-0349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fml3003132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003132%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DBelvin%26aufirst%3DM.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLy%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DEpler%26aufirst%3DJ.%2BA.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DVijapurkar%26aufirst%3DU.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.-H.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520biological%2520profiling%2520of%2520potent%2520and%2520selective%2520mTOR%2520inhibitor%2520GDC-0349%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D103%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Orr, S. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure–activity relationships and discovery strategies to mitigate drug–drug interaction risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4896</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+M.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure%E2%80%93activity+relationships+and+discovery+strategies+to+mitigate+drug%E2%80%93drug+interaction+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug%25E2%2580%2593drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, S. R.</span><span> </span><span class="NLM_article-title">Statistical methods for analysis of time-dependent inhibition of cytochrome P450 enzymes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2289-2296&author=P.+Yatesauthor=H.+Engauthor=L.+Diauthor=S.+R.+Obach&title=Statistical+methods+for+analysis+of+time-dependent+inhibition+of+cytochrome+P450+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DP.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DObach%26aufirst%3DS.%2BR.%26atitle%3DStatistical%2520methods%2520for%2520analysis%2520of%2520time-dependent%2520inhibition%2520of%2520cytochrome%2520P450%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2289%26epage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galetin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, S. C.</span><span> </span><span class="NLM_article-title">Drug–drug interaction potential of marketed oncology drugs: in vitro assessment of time-dependent cytochrome P450 inhibition, reactive metabolite formation and drug–drug interaction prediction</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1960</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=1960-1976&author=J.+R.+Kennyauthor=S.+Mukadamauthor=C.+Zhangauthor=S.+Tayauthor=C.+Collinsauthor=A.+Galetinauthor=S.+C.+Khojasteh&title=Drug%E2%80%93drug+interaction+potential+of+marketed+oncology+drugs%3A+in+vitro+assessment+of+time-dependent+cytochrome+P450+inhibition%2C+reactive+metabolite+formation+and+drug%E2%80%93drug+interaction+prediction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DGaletin%26aufirst%3DA.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26atitle%3DDrug%25E2%2580%2593drug%2520interaction%2520potential%2520of%2520marketed%2520oncology%2520drugs%253A%2520in%2520vitro%2520assessment%2520of%2520time-dependent%2520cytochrome%2520P450%2520inhibition%252C%2520reactive%2520metabolite%2520formation%2520and%2520drug%25E2%2580%2593drug%2520interaction%2520prediction%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D1960%26epage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bredt, J.</span><span> </span><span class="NLM_article-title">Über sterische hinderung in brückenringen (bredtsche regel) und über die meso-trans-stellung in kondensierten ringsystemen des hexamethylens</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1924</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=1924&pages=1-13&author=J.+Bredt&title=%C3%9Cber+sterische+hinderung+in+br%C3%BCckenringen+%28bredtsche+regel%29+und+%C3%BCber+die+meso-trans-stellung+in+kondensierten+ringsystemen+des+hexamethylens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBredt%26aufirst%3DJ.%26atitle%3D%25C3%259Cber%2520sterische%2520hinderung%2520in%2520br%25C3%25BCckenringen%2520%2528bredtsche%2520regel%2529%2520und%2520%25C3%25BCber%2520die%2520meso-trans-stellung%2520in%2520kondensierten%2520ringsystemen%2520des%2520hexamethylens%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1924%26volume%3D437%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><div class="note"><p class="first last">For a review of this topic, see the following:</p></div><span class="NLM_contrib-group">Shea, K. J.</span><span> </span><span class="NLM_article-title">Recent developments in the synthesis, structure and chemistry of bridgehead alkenes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1980&pages=1683-1715&author=K.+J.+Shea&title=Recent+developments+in+the+synthesis%2C+structure+and+chemistry+of+bridgehead+alkenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShea%26aufirst%3DK.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520the%2520synthesis%252C%2520structure%2520and%2520chemistry%2520of%2520bridgehead%2520alkenes%26jtitle%3DTetrahedron%26date%3D1980%26volume%3D36%26spage%3D1683%26epage%3D1715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhJdCIqGWUR8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0lhrRoGGGz1WTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Movassaghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span> </span><span class="NLM_article-title">Single-step synthesis of pyrimidine derivatives</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">14254</span><span class="NLM_x">–</span> <span class="NLM_lpage">14255</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja066405m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKitbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14254-14255&author=M.+Movassaghiauthor=M.+D.+Hill&title=Single-step+synthesis+of+pyrimidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Single-step synthesis of pyrimidine derivatives</span></div><div class="casAuthors">Movassaghi, Mohammad; Hill, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">14254-14255</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A single-step conversion of various N-vinyl and N-aryl amides to the corresponding pyrimidine and quinazoline derivs., resp, e.g., I (R = H, MeO or NO2) was described.  The process involved amide activation with 2-chloropyridine and trifluoromethanesulfonic anhydride followed by nitrile addn. into the reactive intermediate and cycloisomerization.  The use of this chem. with sensitive N-vinyl amides and epimerizable substrates in addn. to a wide range of functional groups was noteworthy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVLTLAyIDRWrVg90H21EOLACvtfcHk0lhrRoGGGz1WTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKitbbJ&md5=66ca82afed67237dd52f26996ce32e7d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja066405m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja066405m%26sid%3Dliteratum%253Aachs%26aulast%3DMovassaghi%26aufirst%3DM.%26aulast%3DHill%26aufirst%3DM.%2BD.%26atitle%3DSingle-step%2520synthesis%2520of%2520pyrimidine%2520derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14254%26epage%3D14255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ahmad, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Movassaghi, M.</span><span> </span><span class="NLM_article-title">Synthesis of densely substituted pyrimidine derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">8460</span><span class="NLM_x">–</span> <span class="NLM_lpage">8463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9017149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=8460-8463&author=O.+K.+Ahmadauthor=M.+D.+Hillauthor=M.+Movassaghi&title=Synthesis+of+densely+substituted+pyrimidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Densely Substituted Pyrimidine Derivatives</span></div><div class="casAuthors">Ahmad, Omar K.; Hill, Matthew D.; Movassaghi, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8460-8463</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using 2-chloropyridine and triflic anhydride as activating agents, unsatd. or arom. amides RCONHR1 [R = cyclohexyl, Ph, MeO2C, (4-MeOC6H4CH2)2N, MeON(Me), PhO; R1 = 1-cyclohexen-1-yl, Ph, 4-MeC6H4, 4-MeOC6H4, PhCH:CH] undergo cyclocondensation reactions with cyanamides, cyanic acid esters, cyanogen bromide, or cyclohexanecarbonitrile R2CN (R2 = 4-morpholinyl, phthalimidyl, PhO, MeS, Br, cyclohexyl) to give pyrimidines and quinazolines such as I (R3 = MeS, Br) in 54-99% yields.  I (R3 = MeS, Br) are converted to I (R3 = H, BuNH, H2N) and the keto tautomer of I (R3 = HO) in 59-100% yields.  Limitations on the method are disclosed.  The method allows access to heterocycles difficult or impossible to prep. by other means.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiu0aNb5KOUrVg90H21EOLACvtfcHk0lhrRoGGGz1WTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artL%252FN&md5=a936dbd2b4f72c5cf5f328358b6648c3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo9017149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9017149%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DO.%2BK.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DMovassaghi%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520densely%2520substituted%2520pyrimidine%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D8460%26epage%3D8463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jean, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span> </span><span class="NLM_article-title">Access to saturated fused pyrimidine derivatives via a flexible <i>N</i>-vinyl tertiary enamide synthesis</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=2387-2391&author=A.+A.+Estradaauthor=J.+P.+Lyssikatosauthor=F.+St-Jeanauthor=P.+Bergeron&title=Access+to+saturated+fused+pyrimidine+derivatives+via+a+flexible+N-vinyl+tertiary+enamide+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DSt-Jean%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DP.%26atitle%3DAccess%2520to%2520saturated%2520fused%2520pyrimidine%2520derivatives%2520via%2520a%2520flexible%2520N-vinyl%2520tertiary%2520enamide%2520synthesis%26jtitle%3DSynlett%26date%3D2011%26volume%3D16%26spage%3D2387%26epage%3D2391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.-Y.+Zhu&title=Discovery+of+%28thienopyrimidin-2-yl%29aminopyrimidines+as+potent%2C+selective%2C+and+orally+available+pan-PI3-kinase+and+dual+pan-PI3-kinase%2FmTOR+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.-Y.%26atitle%3DDiscovery%2520of%2520%2528thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520pan-PI3-kinase%2520and%2520dual%2520pan-PI3-kinase%252FmTOR%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarosa, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span> </span><span class="NLM_article-title">Evaluation of time-dependent cytochrome P450 inhibition in a high-throughput, automated assay: introducing a novel area under the curve shift approach</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.2174%2F187231212800229309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=45-53&author=S.+Mukadamauthor=S.+Tayauthor=D.+Tranauthor=L.+Wangauthor=E.+M.+Delarosaauthor=S.+C.+Khojastehauthor=J.+Halladayauthor=J.+R.+Kenny&title=Evaluation+of+time-dependent+cytochrome+P450+inhibition+in+a+high-throughput%2C+automated+assay%3A+introducing+a+novel+area+under+the+curve+shift+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F187231212800229309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231212800229309%26sid%3Dliteratum%253Aachs%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDelarosa%26aufirst%3DE.%2BM.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26atitle%3DEvaluation%2520of%2520time-dependent%2520cytochrome%2520P450%2520inhibition%2520in%2520a%2520high-throughput%252C%2520automated%2520assay%253A%2520introducing%2520a%2520novel%2520area%2520under%2520the%2520curve%2520shift%2520approach%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2012%26volume%3D6%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The difference in antiproliferative activities for <b>11</b> and <b>15</b> cannot be definitively attributed to plasma protein binding, as there are differences across species between these two compounds and protein binding in fetal bovine serum (10% FBS was used in the antiproliferative assays) was not determined.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Grunwald, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraffenried, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrichs, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span> </span><span class="NLM_article-title">Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6141</span><span class="NLM_x">–</span> <span class="NLM_lpage">6145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6141-6145&author=V.+Grunwaldauthor=L.+DeGraffenriedauthor=D.+Russelauthor=W.+E.+Friedrichsauthor=R.+B.+Rayauthor=M.+Hidalgo&title=Inhibitors+of+mTOR+reverse+doxorubicin+resistance+conferred+by+PTEN+status+in+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrunwald%26aufirst%3DV.%26aulast%3DDeGraffenried%26aufirst%3DL.%26aulast%3DRussel%26aufirst%3DD.%26aulast%3DFriedrichs%26aufirst%3DW.%2BE.%26aulast%3DRay%26aufirst%3DR.%2BB.%26aulast%3DHidalgo%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520mTOR%2520reverse%2520doxorubicin%2520resistance%2520conferred%2520by%2520PTEN%2520status%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6141%26epage%3D6145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Thompson, W.; Claremon, D. A.; Munson, P. M.; Phillips, B.</span><span> </span><span class="NLM_article-title">8-Aza-bicyclo[3.2.1]octane NMDA/NR2B Antagonists</span>. WO 2001032179,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=W.+Thompson&author=D.+A.+Claremon&author=P.+M.+Munson&author=B.+Phillips&title=8-Aza-bicyclo%5B3.2.1%5Doctane+NMDA%2FNR2B+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%26atitle%3D8-Aza-bicyclo%255B3.2.1%255Doctane%2520NMDA%252FNR2B%2520Antagonists%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">For the assignment of stereochemistry of 8-benzyl-8-azabicyclo[3.2.1]octan-2-one isomers via specific rotation, see the following:</p></div><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, H.</span><span> </span><span class="NLM_article-title">Enantiospecific synthesis of natural (−)-cocaine and unnatural (+)-cocaine from <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-glutamic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">4069</span><span class="NLM_x">–</span> <span class="NLM_lpage">4078</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980153t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=4069-4078&author=R.+Linauthor=J.+Castellsauthor=H.+Rapoport&title=Enantiospecific+synthesis+of+natural+%28%E2%88%92%29-cocaine+and+unnatural+%28%2B%29-cocaine+from+d-+and+l-glutamic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo980153t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980153t%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DR.%26aulast%3DCastells%26aufirst%3DJ.%26aulast%3DRapoport%26aufirst%3DH.%26atitle%3DEnantiospecific%2520synthesis%2520of%2520natural%2520%2528%25E2%2588%2592%2529-cocaine%2520and%2520unnatural%2520%2528%252B%2529-cocaine%2520from%2520d-%2520and%2520l-glutamic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D4069%26epage%3D4078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Denmark, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuhashi, H.</span><span> </span><span class="NLM_article-title">Chiral fluoro ketones for catalytic asymmetric epoxidation of alkenes with oxone</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3479</span><span class="NLM_x">–</span> <span class="NLM_lpage">3486</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020050h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=3479-3486&author=S.+E.+Denmarkauthor=H.+Matsuhashi&title=Chiral+fluoro+ketones+for+catalytic+asymmetric+epoxidation+of+alkenes+with+oxone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo020050h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020050h%26sid%3Dliteratum%253Aachs%26aulast%3DDenmark%26aufirst%3DS.%2BE.%26aulast%3DMatsuhashi%26aufirst%3DH.%26atitle%3DChiral%2520fluoro%2520ketones%2520for%2520catalytic%2520asymmetric%2520epoxidation%2520of%2520alkenes%2520with%2520oxone%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D3479%26epage%3D3486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">7-Aza pyrimidoaminotropanes were synthesized using <i>N</i>-Troc as tropane protecting group; see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">MMP-cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3001138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1138-1145&author=X.+Huauthor=Y.+Huauthor=M.+Vogtauthor=D.+Stumpfeauthor=J.+Bajorath&title=MMP-cliffs%3A+systematic+identification+of+activity+cliffs+on+the+basis+of+matched+molecular+pairs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs</span></div><div class="casAuthors">Hu, Xiaoying; Hu, Ye; Vogt, Martin; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1145</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity cliffs are generally defined as pairs of structurally similar compds. having large differences in potency.  The anal. of activity cliffs is of general interest because structure-activity relationship (SAR) determinants can often be deduced from them.  Crit. questions for the study of activity cliffs include how similar compds. should be to qualify as cliff partners, how similarity should be assessed, and how large potency differences between participating compds. should be.  Thus far, activity cliffs have mostly been defined on the basis of calcd. Tanimoto similarity values using structural descriptors, esp. 2D fingerprints.  As any theor. assessment of mol. similarity, this approach has its limitations.  For example, calcd. Tanimoto similarities might often be difficult to reconcile and interpret from a chem. perspective, a point of critique frequently raised in medicinal chem.  Herein, we have explored activity cliffs by considering well-defined substructure replacements instead of calcd. similarity values.  For this purpose, the matched mol. pair (MMP) formalism has been applied.  MMPs were systematically derived from public domain compds., and activity cliffs were extd. from them, termed MMP-cliffs.  The frequency of cliff formation was detd. for compds. active against different targets, MMP-cliffs were analyzed in detail, and re-evaluated on the basis of Tanimoto similarity.  In many instances, chem. intuitive activity cliffs were only detected on the basis of MMPs, but not Tanimoto similarity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCYSOxNqPjGbVg90H21EOLACvtfcHk0li2zHrwLel2kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D&md5=958a76d85d0a06424b43eb1b694cf3ca</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci3001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3001138%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DVogt%26aufirst%3DM.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DMMP-cliffs%253A%2520systematic%2520identification%2520of%2520activity%2520cliffs%2520on%2520the%2520basis%2520of%2520matched%2520molecular%2520pairs%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1138%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">The power of MMPA and a teaching lesson in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1815</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300163y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1815-1816&author=K.+Muller&title=The+power+of+MMPA+and+a+teaching+lesson+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm300163y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300163y%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DThe%2520power%2520of%2520MMPA%2520and%2520a%2520teaching%2520lesson%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1815%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Exploring activity cliffs in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2932</span><span class="NLM_x">–</span> <span class="NLM_lpage">2942</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201706b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2932-2942&author=D.+Stumpfeauthor=J.+Bajorath&title=Exploring+activity+cliffs+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Activity Cliffs in Medicinal Chemistry</span></div><div class="casAuthors">Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2932-2942</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, structure-activity relationships (SARs) have increasingly been studied through mining of large compd. data sets, leading to a renaissance of the activity landscape concept.  In general terms, an activity landscape is defined as any graphical representation that integrates similarity and potency relationships between compds. sharing a specific activity.  From activity landscape representations of different design, both global and local SAR features present in compd. data sets can be extd.  Modeling and rationalizing activity landscapes require the application of computational methods.  As such, the activity landscape concept is of comparable relevance for chemoinformatics (having a strong focus on data mining and representation) and medicinal chem. (given its immediate relevance for SAR anal.).  Herein, we describe in detail the multifaceted nature of activity cliffs, discuss underlying scientific concepts, and explain how their individual or systematic anal. might (or might not) provide useful information for medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1wydp65qQLVg90H21EOLACvtfcHk0lizVlkZalp53w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D&md5=ceddd1de5798b585d6381ac18ba67fc9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm201706b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201706b%26sid%3Dliteratum%253Aachs%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DExploring%2520activity%2520cliffs%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2932%26epage%3D2942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0lizVlkZalp53w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Chemical transformations that yield compounds with distinct activity profiles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=523-527&author=Y.+Huauthor=J.+Bajorath&title=Chemical+transformations+that+yield+compounds+with+distinct+activity+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fml2000609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000609%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DChemical%2520transformations%2520that%2520yield%2520compounds%2520with%2520distinct%2520activity%2520profiles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D523%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">At the time of the PK/PD experiment with <b>20</b>, it was already established from multiple experiments with other mTOR small molecule inhibitors that a single 6 h time point was sufficient to predict the mED.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">mED is defined as the dose required to achieve ED<sub>50</sub> when constrained to 0–100% TGI.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f','cit8g','cit8h','cit8i','cit8j','cit8k','cit8l','cit8m','cit8n','cit8o','cit8p','cit8q','cit8r','cit8s','cit8t','cit8u','cit8v','cit8w','cit8x'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':[],'ref36':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Bull</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Croft</span>, <span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert  Doran</span>, and <span class="hlFld-ContribAuthor ">Kate F.  Morgan</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12150-12233. <a href="https://doi.org/10.1021/acs.chemrev.6b00274" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DOxetanes%25253A%252BRecent%252BAdvances%252Bin%252BSynthesis%25252C%252BReactivity%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBull%26aufirst%3DJames%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D15092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12150%26epage%3D12233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>, <span class="hlFld-ContribAuthor ">Minghua  Sun</span>, <span class="hlFld-ContribAuthor ">Connie  New</span>, <span class="hlFld-ContribAuthor ">Spencer  Nam</span>, <span class="hlFld-ContribAuthor ">Wesley P.  Blackaby</span>, <span class="hlFld-ContribAuthor ">Alastair J.  Hodges</span>, <span class="hlFld-ContribAuthor ">David  Nash</span>, <span class="hlFld-ContribAuthor ">Mizio  Matteucci</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Peter W.  Fan</span>, <span class="hlFld-ContribAuthor ">Suzanne  Tay</span>, and <span class="hlFld-ContribAuthor ">Jae H.  Chang</span>  . </span><span class="cited-content_cbyCitation_article-title">Probing Mechanisms of CYP3A Time-Dependent Inhibition Using a Truncated Model System. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (8)
                                     , 925-929. <a href="https://doi.org/10.1021/acsmedchemlett.5b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProbing%252BMechanisms%252Bof%252BCYP3A%252BTime-Dependent%252BInhibition%252BUsing%252Ba%252BTruncated%252BModel%252BSystem%26aulast%3DWang%26aufirst%3DXiaojing%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D07052015%26date%3D12072015%26date%3D15072015%26date%3D13082015%26date%3D12072015%26volume%3D6%26issue%3D8%26spage%3D925%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benoit  Pasquier</span>, <span class="hlFld-ContribAuthor ">Youssef  El-Ahmad</span>, <span class="hlFld-ContribAuthor ">Bruno  Filoche-Rommé</span>, <span class="hlFld-ContribAuthor ">Christine  Dureuil</span>, <span class="hlFld-ContribAuthor ">Florence  Fassy</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Abecassis</span>, <span class="hlFld-ContribAuthor ">Magali  Mathieu</span>, <span class="hlFld-ContribAuthor ">Thomas  Bertrand</span>, <span class="hlFld-ContribAuthor ">Tsiala  Benard</span>, <span class="hlFld-ContribAuthor ">Cédric  Barrière</span>, <span class="hlFld-ContribAuthor ">Samira  El Batti</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Letallec</span>, <span class="hlFld-ContribAuthor ">Véronique  Sonnefraud</span>, <span class="hlFld-ContribAuthor ">Maurice  Brollo</span>, <span class="hlFld-ContribAuthor ">Laurence  Delbarre</span>, <span class="hlFld-ContribAuthor ">Véronique  Loyau</span>, <span class="hlFld-ContribAuthor ">Fabienne  Pilorge</span>, <span class="hlFld-ContribAuthor ">Luc  Bertin</span>, <span class="hlFld-ContribAuthor ">Patrick  Richepin</span>, <span class="hlFld-ContribAuthor ">Jérôme  Arigon</span>, <span class="hlFld-ContribAuthor ">Jean-Robert  Labrosse</span>, <span class="hlFld-ContribAuthor ">Jacques  Clément</span>, <span class="hlFld-ContribAuthor ">Florence  Durand</span>, <span class="hlFld-ContribAuthor ">Romain  Combet</span>, <span class="hlFld-ContribAuthor ">Pierre  Perraut</span>, <span class="hlFld-ContribAuthor ">Vincent  Leroy</span>, <span class="hlFld-ContribAuthor ">Frédéric  Gay</span>, <span class="hlFld-ContribAuthor ">Dominique  Lefrançois</span>, <span class="hlFld-ContribAuthor ">François  Bretin</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Marquette</span>, <span class="hlFld-ContribAuthor ">Nadine  Michot</span>, <span class="hlFld-ContribAuthor ">Anne  Caron</span>, <span class="hlFld-ContribAuthor ">Christelle  Castell</span>, <span class="hlFld-ContribAuthor ">Laurent  Schio</span>, <span class="hlFld-ContribAuthor ">Gary  McCort</span>, <span class="hlFld-ContribAuthor ">Hélène  Goulaouic</span>, <span class="hlFld-ContribAuthor ">Carlos  Garcia-Echeverria</span>, and <span class="hlFld-ContribAuthor ">Baptiste  Ronan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2S)-8-[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 376-400. <a href="https://doi.org/10.1021/jm5013352" title="DOI URL">https://doi.org/10.1021/jm5013352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5013352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5013352%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282S%252529-8-%25255B%2525283R%252529-3-Methylmorpholin-4-yl%25255D-1-%2525283-methyl-2-oxobutyl%252529-2-%252528trifluoromethyl%252529-3%25252C4-dihydro-2H-pyrimido%25255B1%25252C2-a%25255Dpyrimidin-6-one%25253A%252BA%252BNovel%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BVps34%252Bfor%252Bthe%252BTreatment%252Bof%252BSolid%252BTumors%26aulast%3DPasquier%26aufirst%3DBenoit%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D01092014%26date%3D26112014%26date%3D08012015%26date%3D17112014%26volume%3D58%26issue%3D1%26spage%3D376%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Xu</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112391. <a href="https://doi.org/10.1016/j.ejmech.2020.112391" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112391%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BmTOR%252Bfor%252Bfighting%252Bdiseases%25253A%252BA%252Brevisited%252Breview%252Bof%252BmTOR%252Binhibitors%26aulast%3DXu%26aufirst%3DTian%26date%3D2020%26volume%3D199%26spage%3D112391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Hélène  Montané</span>, <span class="hlFld-ContribAuthor ">Benoît  Menand</span>. </span><span class="cited-content_cbyCitation_article-title">TOR inhibitors: from mammalian outcomes to pharmacogenetics in plants and algae. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Botany</span><span> <strong>2019,</strong> <em>70 </em>
                                    (8)
                                     , 2297-2312. <a href="https://doi.org/10.1093/jxb/erz053" title="DOI URL">https://doi.org/10.1093/jxb/erz053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jxb/erz053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjxb%2Ferz053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Botany%26atitle%3DTOR%252Binhibitors%25253A%252Bfrom%252Bmammalian%252Boutcomes%252Bto%252Bpharmacogenetics%252Bin%252Bplants%252Band%252Balgae%26aulast%3DMontan%25C3%25A9%26aufirst%3DMarie-H%25C3%25A9l%25C3%25A8ne%26date%3D2019%26date%3D2019%26volume%3D70%26issue%3D8%26spage%3D2297%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed S.  Abdel‐Maksoud</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El‐Gamal</span>, <span class="hlFld-ContribAuthor ">Dalia Reyane  Benhalilou</span>, <span class="hlFld-ContribAuthor ">Sandy  Ashraf</span>, <span class="hlFld-ContribAuthor ">Shatha Abdulghaffar  Mohammed</span>, <span class="hlFld-ContribAuthor ">Chang‐Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (2)
                                     , 631-664. <a href="https://doi.org/10.1002/med.21535" title="DOI URL">https://doi.org/10.1002/med.21535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21535%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMechanistic%25252Fmammalian%252Btarget%252Bof%252Brapamycin%25253A%252BRecent%252Bpathological%252Baspects%252Band%252Binhibitors%26aulast%3DAbdel%25E2%2580%2590Maksoud%26aufirst%3DMohammed%2BS.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D2%26spage%3D631%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dajun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Yan</span>, <span class="hlFld-ContribAuthor ">Ge  Jin</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Ma</span>, <span class="hlFld-ContribAuthor ">Dan  Han</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Jia</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor evaluation of novel 4-anilino-7,8-dihydropyrido[4,3-
              d
              ]pyrimidine-6(5
              H
              )-carboxylate derivatives as potential EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (9)
                                     , 1800110. <a href="https://doi.org/10.1002/ardp.201800110" title="DOI URL">https://doi.org/10.1002/ardp.201800110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800110%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252Bantitumor%252Bevaluation%252Bof%252Bnovel%252B4-anilino-7%25252C8-dihydropyrido%25255B4%25252C3-%252Bd%252B%25255Dpyrimidine-6%2525285%252BH%252B%252529-carboxylate%252Bderivatives%252Bas%252Bpotential%252BEGFR%252Binhibitors%26aulast%3DZhang%26aufirst%3DDajun%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D9%26spage%3D1800110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Udit  Chaube</span>, <span class="hlFld-ContribAuthor ">Hardik  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2017,</strong> <em>21 </em>
                                    (3)
                                     , 741-759. <a href="https://doi.org/10.1007/s11030-017-9752-9" title="DOI URL">https://doi.org/10.1007/s11030-017-9752-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-017-9752-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-017-9752-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3D3D-QSAR%25252C%252Bmolecular%252Bdynamics%252Bsimulations%25252C%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bon%252Bpyridoaminotropanes%252Band%252Btetrahydroquinazoline%252Bas%252BmTOR%252Binhibitors%26aulast%3DChaube%26aufirst%3DUdit%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D3%26spage%3D741%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Takaharu  Hirayama</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Hirata</span>, <span class="hlFld-ContribAuthor ">Yukiko  Hikichi</span>, <span class="hlFld-ContribAuthor ">Saomi  Murai</span>, <span class="hlFld-ContribAuthor ">Maki  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Yuka  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Kazuko  Yonemori</span>, <span class="hlFld-ContribAuthor ">Akito  Hata</span>, <span class="hlFld-ContribAuthor ">Kazunobu  Aoyama</span>, <span class="hlFld-ContribAuthor ">Douglas R.  Cary</span>. </span><span class="cited-content_cbyCitation_article-title">Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (12)
                                     , 3018-3033. <a href="https://doi.org/10.1016/j.bmc.2017.03.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStudies%252Bof%252BCDK%252B8%25252F19%252Binhibitors%25253A%252BDiscovery%252Bof%252Bnovel%252Band%252Bselective%252BCDK8%25252F19%252Bdual%252Binhibitors%252Band%252Belimination%252Bof%252Btheir%252BCYP3A4%252Btime-dependent%252Binhibition%252Bpotential%26aulast%3DFujimoto%26aufirst%3DJun%26date%3D2017%26volume%3D25%26issue%3D12%26spage%3D3018%26epage%3D3033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beibei  Mao</span>, <span class="hlFld-ContribAuthor ">Shanyun  Gao</span>, <span class="hlFld-ContribAuthor ">Yiran  Weng</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of imidazo[1,2- b ]pyridazine derivatives as mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>129 </em>, 135-150. <a href="https://doi.org/10.1016/j.ejmech.2017.02.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazine%252Bderivatives%252Bas%252BmTOR%252Binhibitors%26aulast%3DMao%26aufirst%3DBeibei%26date%3D2017%26volume%3D129%26spage%3D135%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig  Fraser</span>, <span class="hlFld-ContribAuthor ">Neil O.  Carragher</span>, <span class="hlFld-ContribAuthor ">Asier  Unciti-Broceta</span>. </span><span class="cited-content_cbyCitation_article-title">eCF309
              : a potent, selective and cell-permeable mTOR inhibitor. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 471-477. <a href="https://doi.org/10.1039/C5MD00493D" title="DOI URL">https://doi.org/10.1039/C5MD00493D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00493D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00493D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DeCF309%252B%25253A%252Ba%252Bpotent%25252C%252Bselective%252Band%252Bcell-permeable%252BmTOR%252Binhibitor%26aulast%3DFraser%26aufirst%3DCraig%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D471%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Meng  Zhao</span>, <span class="hlFld-ContribAuthor ">Lixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Shuchun  Guo</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluations. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4591-4607. <a href="https://doi.org/10.1016/j.bmc.2015.05.059" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Banti-proliferative%252Bagents%252Band%252Bpotential%252Binhibitors%252Bof%252BEGFR%252Btyrosine%252Bkinases%252Bbased%252Bon%252B4-anilinotetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidine%252Bscaffold%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluations%26aulast%3DZhang%26aufirst%3DYong%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4591%26epage%3D4607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">James A.  Bull</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Di-, Tri-, and Tetrasubstituted Oxetanes by Rhodium-Catalyzed OH Insertion and CC Bond-Forming Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (51)
                                     , 14454-14458. <a href="https://doi.org/10.1002/ange.201408928" title="DOI URL">https://doi.org/10.1002/ange.201408928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201408928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201408928%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSynthesis%252Bof%252BDi-%25252C%252BTri-%25252C%252Band%252BTetrasubstituted%252BOxetanes%252Bby%252BRhodium-Catalyzed%252BO%2525EF%2525A3%2525BFH%252BInsertion%252Band%252BC%2525EF%2525A3%2525BFC%252BBond-Forming%252BCyclization%26aulast%3DDavis%26aufirst%3DOwen%2BA.%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D51%26spage%3D14454%26epage%3D14458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">James A.  Bull</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Di-, Tri-, and Tetrasubstituted Oxetanes by Rhodium-Catalyzed OH Insertion and CC Bond-Forming Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (51)
                                     , 14230-14234. <a href="https://doi.org/10.1002/anie.201408928" title="DOI URL">https://doi.org/10.1002/anie.201408928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201408928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201408928%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSynthesis%252Bof%252BDi-%25252C%252BTri-%25252C%252Band%252BTetrasubstituted%252BOxetanes%252Bby%252BRhodium-Catalyzed%252BO%2525EF%2525A3%2525BFH%252BInsertion%252Band%252BC%2525EF%2525A3%2525BFC%252BBond-Forming%252BCyclization%26aulast%3DDavis%26aufirst%3DOwen%2BA.%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D51%26spage%3D14230%26epage%3D14234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Zhihong  Liu</span>, <span class="hlFld-ContribAuthor ">Minghao  Zheng</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, . </span><span class="cited-content_cbyCitation_article-title">Predicting mTOR Inhibitors with a Classifier Using Recursive Partitioning and Naïve Bayesian Approaches. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (5)
                                     , e95221. <a href="https://doi.org/10.1371/journal.pone.0095221" title="DOI URL">https://doi.org/10.1371/journal.pone.0095221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0095221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0095221%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DPredicting%252BmTOR%252BInhibitors%252Bwith%252Ba%252BClassifier%252BUsing%252BRecursive%252BPartitioning%252Band%252BNa%2525C3%2525AFve%252BBayesian%252BApproaches%26aulast%3DWang%26aufirst%3DLing%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D5%26spage%3De95221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwangseo  Park</span>, <span class="hlFld-ContribAuthor ">Hyeonjeong  Choe</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 835-838. <a href="https://doi.org/10.1016/j.bmcl.2013.12.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVirtual%252Bscreening%252Band%252Bbiochemical%252Bevaluation%252Bto%252Bidentify%252Bnew%252Binhibitors%252Bof%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DPark%26aufirst%3DHwangseo%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D835%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benito  Alcaide</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 85-113. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00004-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00004-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00004-2%26sid%3Dliteratum%253Aachs%26atitle%3DFour-Membered%252BRing%252BSystems%26aulast%3DAlcaide%26aufirst%3DBenito%26date%3D2014%26spage%3D85%26epage%3D113%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Lichuan  Lin</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>. </span><span class="cited-content_cbyCitation_article-title">A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (18)
                                     , 5097-5104. <a href="https://doi.org/10.1016/j.bmcl.2013.07.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bhit%252Bto%252Blead%252Bdiscovery%252Bof%252Bnovel%252BN-methylated%252Bimidazolo-%25252C%252Bpyrrolo-%25252C%252Band%252Bpyrazolo-pyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Binhibitors%26aulast%3DLee%26aufirst%3DWendy%26date%3D2013%26volume%3D23%26issue%3D18%26spage%3D5097%26epage%3D5104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of clinical candidate <b>1</b> and one of two potential reactive iminium species of the THQ series and design rationale for PATs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Depiction of 7-aza-PAT <b>20</b> (GNE-555) (yellow) in the active site of the mTOR homology model<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> with residues important for binding and selectivity vs PI3Kγ shown. View is edge-on to the plane of the inhibitor bicyclic ring. Hydrogen bonds to the protein are shown as thin dashed lines. A vdW surface on the protein color-coded by lipophilic potential (tan-brown = lipophilic, cyan-blue = polar, green = between lipophilic and polar) has been added. Note the proximity of the lipophilic portions of the tropane and (<i>S</i>)-3-methylmorpholine ring to the lipophilic portions of the protein. The oxetane ring extends toward solvent. Image was generated using Benchware3DExplorer (Tripos Inc., St. Louis, MO).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 6-Aza-PATs via Pyrimidine Synthetic Methodology<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PMBNH<sub>2</sub>, Ti(OEt)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 16 h, then Et<sub>3</sub>N, <i>p</i>-NO<sub>2</sub>BzCl, 0–25 °C, 84%; (b) (<i>S</i>)-3-methylmorpholine-4-carbonitrile, Tf<sub>2</sub>O, 2-ClPyr, CH<sub>2</sub>Cl<sub>2</sub>, −78 to 25 °C, 40%; (c) SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, Δ; (d) triphosgene, Et<sub>3</sub>N, 1,2-DCE, 0–70 °C, then EtNH<sub>2</sub>·HCl, 25 °C; (e) Pd(PPh<sub>3</sub>)<sub>4</sub>, morpholine, THF, 0 °C; (f) see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of low energy docked models of tropanes <b>11</b> (pink) and <b>12</b> (green). PI3Kγ residues are in cyan, and the corresponding mTOR residues are in gray. mTOR numbering is shown. Note the closer contact of the oxetane ring to the Trp ring in PI3Kγ (W812 in PI3Kγ; K2171 in mTOR) for <b>11</b>, consistent with its increased mTOR selectivity relative to <b>12</b>. Both <b>11</b> and <b>12</b> are well accommodated by mTOR because of the less bulky K2171 residue providing a larger binding cavity. In this view, W2239 in mTOR occurs behind the inhibitor oxetane rings of <b>11</b> and <b>12</b> and does not sterically clash. Image was generated using Benchware3DExplorer (Tripos Inc., St. Louis, MO).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Matched pair comparison of 6-aza-THQ (<b>15</b>) and 6-aza-PAT (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo target modulation of mTOR pathway in NCI-PC3 human prostate tumor xenografts with <b>8</b> administered as a single oral dose to tumor-bearing mice. Plasma samples were collected at 1, 6, and 10 h postdose and analyzed for drug exposure and PD biomarker modulation. Target inhibition was calculated relative to the average time-matched vehicle control. Error bars indicate ± standard error of the mean. Four mice were dosed, and phosphoprotein levels were measured in duplicate samples for each mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 7-Aza-PATs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a></p></p></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Direct comparison of NCI-PC3 antiproliferative cellular activities of 7-aza-PAT (<b>20</b>–<b>23</b>, green) and respective 7-aza-THQ (red) matched pairs. (B) Direct comparison of in vivo mouse plasma clearances of 7-aza-PAT (<b>20</b>–<b>23</b>, green) and respective 7-aza-THQ (red) matched pairs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/medium/jm-2013-00194n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) In vivo target modulation of mTOR pathway in NCI-PC3 human prostate tumor xenografts with <b>20</b>. Administered as a single oral dose to tumor-bearing mice. Plasma samples were collected 6 h postdose and analyzed for drug exposure and PD biomarker modulation. Target inhibition was calculated relative to the average time-matched vehicle control. Error bars indicate ± standard error of the mean. Four mice were dosed for each compound and phosphoprotein levels were measured in duplicate samples for each mouse. (B) In vivo efficacy study with <b>20</b> in the MCF7neo/Her2 breast cancer model. LME = linear mixed effects model. The plot shows tumor volumes over time including a vehicle cohort. Vehicle = MCT = 0.5% methylcellulose/0.2% Tween-80; QD = every day.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-7/jm400194n/production/images/large/jm-2013-00194n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400194n&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Don, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. F.</span><span> </span><span class="NLM_article-title">Recent clinical trials of mTOR-targeted cancer therapies</span> <span class="citation_source-journal">Rev. Recent Clin. Trials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.2174%2F157488711793980147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=20868343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A280%3ADC%252BC3M7hsFyrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=24-35&author=A.+S.+Donauthor=X.+F.+Zheng&title=Recent+clinical+trials+of+mTOR-targeted+cancer+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent clinical trials of mTOR-targeted cancer therapies</span></div><div class="casAuthors">Don Aruni S Arachchige; Zheng X F Steven</div><div class="citationInfo"><span class="NLM_cas:title">Reviews on recent clinical trials</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) is a central component within a complex intracellular signaling network that regulates various processes including cell growth, proliferation, metabolism, and angiogenesis.  A hyperactive PI3k/Akt/mTOR signaling pathway is found in many human cancers and alterations in this pathway is associated with the development and progression of cancer.  Drugs that target and inhibit mTOR activity are therefore expected to provide therapeutic value in a number of cancer types.  Several classes of mTOR-targeted therapeutics are currently being evaluated in cancer clinical trials, including the rapamycins, dual PI3K-mTOR inhibitors, and ATP-competitive mTORC1/2 inhibitors.  This review summarizes important findings from recently completed trials of mTOR inhibitors and also discusses preliminary data from ongoing trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRdTZMd7ktETToTC3aBaesfW6udTcc2eYXreFJkqLRTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7hsFyrtg%253D%253D&md5=16a8a3d6b8778e70e7ed4eabd9dfcc76</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F157488711793980147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157488711793980147%26sid%3Dliteratum%253Aachs%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DZheng%26aufirst%3DX.%2BF.%26atitle%3DRecent%2520clinical%2520trials%2520of%2520mTOR-targeted%2520cancer%2520therapies%26jtitle%3DRev.%2520Recent%2520Clin.%2520Trials%26date%3D2011%26volume%3D6%26spage%3D24%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahmoud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span> </span><span class="NLM_article-title">Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1056%2FNEJMoa1109653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=22149876" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2011&pages=520-529&author=J.+Baselgaauthor=M.+Camponeauthor=M.+Piccartauthor=H.+A.+Burrisauthor=H.+S.+Rugoauthor=T.+Sahmoudauthor=S.+Noguchiauthor=M.+Gnantauthor=K.+I.+Pritchardauthor=F.+Lebrunauthor=J.+T.+Beckauthor=Y.+Itoauthor=D.+Yardleyauthor=I.+Deleuauthor=A.+Perezauthor=T.+Bachelotauthor=L.+Vittoriauthor=Z.+Xuauthor=P.+Mukhopadhyayauthor=D.+Lebwohlauthor=G.+N.+Hortobagyi&title=Everolimus+in+postmenopausal+hormone-receptor-positive+advanced+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1109653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1109653%26sid%3Dliteratum%253Aachs%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DCampone%26aufirst%3DM.%26aulast%3DPiccart%26aufirst%3DM.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DSahmoud%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DS.%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLebrun%26aufirst%3DF.%26aulast%3DBeck%26aufirst%3DJ.%2BT.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DYardley%26aufirst%3DD.%26aulast%3DDeleu%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DBachelot%26aufirst%3DT.%26aulast%3DVittori%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26atitle%3DEverolimus%2520in%2520postmenopausal%2520hormone-receptor-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D366%26spage%3D520%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-competitive+mammalian+target+of+rapamycin+inhibitor+reveals+rapamycin-resistant+functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0lh210f6WqiFaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520reveals%2520rapamycin-resistant%2520functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e38&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-site+inhibitors+of+mTOR+target+rapamycin-resistant+outputs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-site%2520inhibitors%2520of%2520mTOR%2520target%2520rapamycin-resistant%2520outputs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3De38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Sun, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span> </span><span class="NLM_article-title">Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">7052</span><span class="NLM_x">–</span> <span class="NLM_lpage">7058</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=7052-7058&author=S.+Y.+Sunauthor=L.+M.+Rosenbergauthor=X.+Wangauthor=Z.+Zhouauthor=P.+Yueauthor=H.+Fuauthor=F.+R.+Khuri&title=Activation+of+Akt+and+eIF4E+survival+pathways+by+rapamycin-mediated+mammalian+target+of+rapamycin+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DRosenberg%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26atitle%3DActivation%2520of%2520Akt%2520and%2520eIF4E%2520survival%2520pathways%2520by%2520rapamycin-mediated%2520mammalian%2520target%2520of%2520rapamycin%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D7052%26epage%3D7058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkavy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grohar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helman, L. J.</span><span> </span><span class="NLM_article-title">Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1932</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1932-1940&author=X.+Wanauthor=B.+Harkavyauthor=N.+Shenauthor=P.+Groharauthor=L.+J.+Helman&title=Rapamycin+induces+feedback+activation+of+Akt+signaling+through+an+IGF-1R-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DX.%26aulast%3DHarkavy%26aufirst%3DB.%26aulast%3DShen%26aufirst%3DN.%26aulast%3DGrohar%26aufirst%3DP.%26aulast%3DHelman%26aufirst%3DL.%2BJ.%26atitle%3DRapamycin%2520induces%2520feedback%2520activation%2520of%2520Akt%2520signaling%2520through%2520an%2520IGF-1R-dependent%2520mechanism%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1932%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.-G.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+cellular%2C+and+in+vivo+activity+of+novel+ATP-competitive+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%252C%2520and%2520in%2520vivo%2520activity%2520of%2520novel%2520ATP-competitive%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7942</span><span class="NLM_x">–</span> <span class="NLM_lpage">7945</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901415x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7942-7945&author=A.+Zaskauthor=J.+Kaplanauthor=J.+C.+Verheijenauthor=D.+J.+Richardauthor=K.+Curranauthor=N.+Brooijmansauthor=E.+M.+Bennettauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=K.+Yu&title=Morpholine+derivatives+greatly+enhance+the+selectivity+of+mammalian+target+of+rapamycin+%28mTOR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors</span></div><div class="casAuthors">Zask, Arie; Kaplan, Joshua; Verheijen, Jeroen C.; Richard, David J.; Curran, Kevin; Brooijmans, Natasja; Bennett, Eric M.; Toral-Barza, Lourdes; Hollander, Irwin; Ayral-Kaloustian, Semiramis; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7942-7945</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dramatic improvements in mTOR-targeting selectivity were achieved by replacing morpholine in pyrazolopyrimidine inhibitors with bridged morpholines.  Analogs I [R1 = (R)- or (S)-3-methyl-4-morpholinyl, 2-methyl-4-morpholinyl, 8-oxa-3-azabicyclo[3.2.1]octan-3-yl, etc.; R2 = Me, Et, cyclopropyl, FCH2CH2, 3-pyridyl, 4-pyridyl; R3 = F3CCH2, 1-methoxycarbonyl-4-piperidinyl, 1-ethoxycarbonyl-4-piperidinyl, 3-pyridylmethyl] with subnanomolar mTOR IC50 values and up to 26000-fold selectivity vs. PI3Kα were prepd.  Chiral morpholines gave inhibitors whose enantiomers had different selectivity and potency profiles.  Mol. modeling suggests that a single amino acid difference between PI3K and mTOR (Phe961Leu) accounts for the profound selectivity seen by creating a deeper pocket in mTOR that can accommodate bridged morpholines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK2HnMHqTHqbVg90H21EOLACvtfcHk0lgZxoTUVIwb4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWrtb3J&md5=5ef1eee5aa79531970049d3d26b46eb2</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm901415x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901415x%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DMorpholine%2520derivatives%2520greatly%2520enhance%2520the%2520selectivity%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7942%26epage%3D7945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">García Martínez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garc%C3%ADa+Mart%C3%ADnezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%2BMart%25C3%25ADnez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Menear, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fundo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, G.</span><span> </span><span class="NLM_article-title">Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5898</span><span class="NLM_x">–</span> <span class="NLM_lpage">5901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5898-5901&author=K.+A.+Menearauthor=S.+Gomezauthor=K.+Malaguauthor=C.+Baileyauthor=K.+Blackburnauthor=X.-L.+Cockcroftauthor=S.+Ewenauthor=A.+Fundoauthor=A.+L.+Gallauthor=G.+Hermann&title=Identification+and+optimisation+of+novel+and+selective+small+molecular+weight+kinase+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenear%26aufirst%3DK.%2BA.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DBlackburn%26aufirst%3DK.%26aulast%3DCockcroft%26aufirst%3DX.-L.%26aulast%3DEwen%26aufirst%3DS.%26aulast%3DFundo%26aufirst%3DA.%26aulast%3DGall%26aufirst%3DA.%2BL.%26aulast%3DHermann%26aufirst%3DG.%26atitle%3DIdentification%2520and%2520optimisation%2520of%2520novel%2520and%2520selective%2520small%2520molecular%2520weight%2520kinase%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5898%26epage%3D5901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzewiecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, M. J.</span><span> </span><span class="NLM_article-title">The discovery and optimisation of pyrido[2,3-<i>d</i>]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5950</span><span class="NLM_x">–</span> <span class="NLM_lpage">5953</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5950-5953&author=K.+Malaguauthor=H.+Dugganauthor=K.+Menearauthor=M.+Hummersoneauthor=S.+Gomezauthor=C.+Baileyauthor=P.+Edwardsauthor=J.+Drzewieckiauthor=F.+Lerouxauthor=M.+J.+Quesada&title=The+discovery+and+optimisation+of+pyrido%5B2%2C3-d%5Dpyrimidine-2%2C4-diamines+as+potent+and+selective+inhibitors+of+mTOR+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DDuggan%26aufirst%3DH.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DDrzewiecki%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DQuesada%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520discovery%2520and%2520optimisation%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidine-2%252C4-diamines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mTOR%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5950%26epage%3D5953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7081</span><span class="NLM_x">–</span> <span class="NLM_lpage">7089</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012642" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7081-7089&author=P.+Nowakauthor=D.+C.+Coleauthor=N.+Brooijmansauthor=M.+G.+Bursavichauthor=K.+J.+Curranauthor=J.+W.+Ellingboeauthor=J.+J.+Gibbonsauthor=I.+Hollanderauthor=Y.+Huauthor=J.+Kaplanauthor=D.+J.+Malwitzauthor=L.+Toral-Barzaauthor=J.+C.+Verheijenauthor=A.+Zaskauthor=W.-G.+Zhangauthor=K.+Yu&title=Discovery+of+potent+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1021%2Fjm9012642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012642%26sid%3Dliteratum%253Aachs%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7081%26epage%3D7089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5013</span><span class="NLM_x">–</span> <span class="NLM_lpage">5016</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900851f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5013-5016&author=A.+Zaskauthor=J.+C.+Verheijenauthor=K.+Curranauthor=J.+Kaplanauthor=D.+J.+Richardauthor=P.+Nowakauthor=D.+J.+Malwitzauthor=N.+Brooijmansauthor=J.+Bardauthor=K.+Svensonauthor=J.+Lucasauthor=L.+Toral-Barzaauthor=W.-G.+Zhangauthor=I.+Hollanderauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=K.+Yu&title=ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin%3A+design+and+synthesis+of+highly+potent+and+selective+pyrazolopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1021%2Fjm900851f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900851f%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%253A%2520design%2520and%2520synthesis%2520of%2520highly%2520potent%2520and%2520selective%2520pyrazolopyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5013%26epage%3D5016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 2-arylthieno[3.2-<i>d</i>]pyrimidines containing 8-oxa-3-azabicyclo[3.2.1]octane in the 4-position as potent inhibitors of mTOR with selectivity over PI3K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=375-379&author=J.+C.+Verheijenauthor=K.+Yuauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=A.+Zask&title=Discovery+of+2-arylthieno%5B3.2-d%5Dpyrimidines+containing+8-oxa-3-azabicyclo%5B3.2.1%5Doctane+in+the+4-position+as+potent+inhibitors+of+mTOR+with+selectivity+over+PI3K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25202-arylthieno%255B3.2-d%255Dpyrimidines%2520containing%25208-oxa-3-azabicyclo%255B3.2.1%255Doctane%2520in%2520the%25204-position%2520as%2520potent%2520inhibitors%2520of%2520mTOR%2520with%2520selectivity%2520over%2520PI3K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D375%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummersone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guichard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span> </span><span class="NLM_article-title">AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=288-298&author=C.+M.+Chrestaauthor=B.+R.+Daviesauthor=I.+Hicksonauthor=T.+Hardingauthor=S.+Cosulichauthor=S.+E.+Critchlowauthor=J.+P.+Vincentauthor=R.+Ellstonauthor=D.+Jonesauthor=P.+Siniauthor=D.+Jamesauthor=Z.+Howardauthor=P.+Dudleyauthor=G.+Hughesauthor=L.+Smithauthor=S.+Maguireauthor=M.+Hummersoneauthor=K.+Malaguauthor=K.+Menearauthor=R.+Jenkinsauthor=M.+Jacobsenauthor=G.+C.+M.+Smithauthor=S.+Guichardauthor=M.+Pass&title=AZD8055+is+a+potent%2C+selective%2C+and+orally+bioavailable+ATP-competitive+mammalian+target+of+rapamycin+kinase+inhibitor+with+in+vitro+and+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DHarding%26aufirst%3DT.%26aulast%3DCosulich%26aufirst%3DS.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DVincent%26aufirst%3DJ.%2BP.%26aulast%3DEllston%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DSini%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DZ.%26aulast%3DDudley%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DMaguire%26aufirst%3DS.%26aulast%3DHummersone%26aufirst%3DM.%26aulast%3DMalagu%26aufirst%3DK.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DJenkins%26aufirst%3DR.%26aulast%3DJacobsen%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DG.%2BC.%2BM.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DPass%26aufirst%3DM.%26atitle%3DAZD8055%2520is%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520kinase%2520inhibitor%2520with%2520in%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D288%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markhard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[<i>h</i>][1,6]naphthyridin-2(1<i>H</i>)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7146</span><span class="NLM_x">–</span> <span class="NLM_lpage">7155</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101144f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7146-7155&author=Q.+Liuauthor=J.+W.+Changauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=A.+Markhardauthor=W.+Hurauthor=J.+Zhangauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+1-%284-%284-propionylpiperazin-1-yl%29-3-%28trifluoromethyl%29phenyl%29-9-%28quinolin-3-yl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+as+a+highly+potent%2C+selective+mammalian+target+of+rapamycin+%28mTOR%29+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8j&amp;dbid=16384&amp;doi=10.1021%2Fjm101144f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101144f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DMarkhard%26aufirst%3DA.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25201-%25284-%25284-propionylpiperazin-1-yl%2529-3-%2528trifluoromethyl%2529phenyl%2529-9-%2528quinolin-3-yl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520as%2520a%2520highly%2520potent%252C%2520selective%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7146%26epage%3D7155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Discovery of 3,6-dihydro-2<i>H</i>-pyran as a morpholine replacement in 6-aryl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines and 2-arylthieno[3,2-<i>d</i>]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2009.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=19963384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=640-643&author=J.+Kaplanauthor=J.+C.+Verheijenauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+3%2C6-dihydro-2H-pyran+as+a+morpholine+replacement+in+6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+and+2-arylthieno%5B3%2C2-d%5Dpyrimidines%3A+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8kR"><div class="casContent"><span class="casTitleNuber">8k</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span></div><div class="casAuthors">Kaplan, Joshua; Verheijen, Jeroen C.; Brooijmans, Natasja; Toral-Barza, Lourdes; Hollander, Irwin; Yu, Ker; Zask, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">640-643</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The morpholine hinge-region binding group on a series of pyrazolopyrimidine and thienopyrimidine mammalian target of rapamycin (mTOR) inhibitors was replaced with 3,6-dihydro-2H-pyran (DHP), giving compds. of equiv. potency and selectivity vs. PI3K.  These results establish the DHP group as a hinge-region binding motif for the prepn. of highly potent and selective mTOR inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBTLsFT9FBubVg90H21EOLACvtfcHk0lgS64___431vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE&md5=9398107e05207e302a8358103f31fb2f</span></div><a href="/servlet/linkout?suffix=cit8k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25203%252C6-dihydro-2H-pyran%2520as%2520a%2520morpholine%2520replacement%2520in%25206-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520and%25202-arylthieno%255B3%252C2-d%255Dpyrimidines%253A%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D640%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Curran, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 1-substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1440</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1440-1444&author=K.+J.+Curranauthor=J.+C.+Verheijenauthor=J.+Kaplanauthor=D.+J.+Richardauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=J.+Lucasauthor=S.+Ayral-Kaloustianauthor=K.+Yuauthor=A.+Zask&title=Pyrazolopyrimidines+as+highly+potent+and+selective%2C+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29%3A+optimization+of+the+1-substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DPyrazolopyrimidines%2520as%2520highly%2520potent%2520and%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%253A%2520optimization%2520of%2520the%25201-substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1440%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">4-Substituted-7-azaindoles bearing a ureidobenzofuranone moiety as potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2259-2263&author=H.-R.+Tsouauthor=G.+MacEwanauthor=G.+Birnbergauthor=N.+Zhangauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=S.+Ayral-Kaloustianauthor=K.+Yu&title=4-Substituted-7-azaindoles+bearing+a+ureidobenzofuranone+moiety+as+potent+and+selective%2C+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3D4-Substituted-7-azaindoles%2520bearing%2520a%2520ureidobenzofuranone%2520moiety%2520as%2520potent%2520and%2520selective%252C%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2259%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2644</span><span class="NLM_x">–</span> <span class="NLM_lpage">2647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8n&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2010.02.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8n&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=20227881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8n&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVGntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2644-2647&author=A.+Zaskauthor=J.+C.+Verheijenauthor=D.+J.+Richardauthor=J.+Kaplanauthor=K.+Curranauthor=L.+Toral-Barzaauthor=J.+Lucasauthor=I.+Hollanderauthor=K.+Yu&title=Discovery+of+2-ureidophenyltriazines+bearing+bridged+morpholines+as+potent+and+selective+ATP-competitive+mTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8nR"><div class="casContent"><span class="casTitleNuber">8n</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors</span></div><div class="casAuthors">Zask, Arie; Verheijen, Jeroen C.; Richard, David J.; Kaplan, Joshua; Curran, Kevin; Toral-Barza, Lourdes; Lucas, Judy; Hollander, Irwin; Yu, Ker</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2644-2647</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Incorporation of bridged morpholines in monocyclic triazine PI3K/mTOR inhibitors gave compds. with increased mTOR selectivity relative to the corresponding morpholine analogs.  Compds. with ureidophenyl groups gave highly potent and selective mTOR inhibitors.  Potency and selectivity was demonstrated both in vitro and in vivo through biomarker suppression studies.  Select compds. exhibited potent inhibition of tumor growth in nude mouse xenograft assays upon PO and IV administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUPE--c1OgzbVg90H21EOLACvtfcHk0lhOXtJDEyyGUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVGntro%253D&md5=d5008526e962f9dd110bfb47306c551e</span></div><a href="/servlet/linkout?suffix=cit8n&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.045%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDiscovery%2520of%25202-ureidophenyltriazines%2520bearing%2520bridged%2520morpholines%2520as%2520potent%2520and%2520selective%2520ATP-competitive%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2644%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Richard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Triazines incorporating (<i>R</i>)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kalpha</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2654</span><span class="NLM_x">–</span> <span class="NLM_lpage">2657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2654-2657&author=D.+J.+Richardauthor=J.+C.+Verheijenauthor=K.+Yuauthor=A.+Zask&title=Triazines+incorporating+%28R%29-3-methylmorpholine+are+potent+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29+with+selectivity+over+PI3Kalpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DD.%2BJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DTriazines%2520incorporating%2520%2528R%2529-3-methylmorpholine%2520are%2520potent%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520with%2520selectivity%2520over%2520PI3Kalpha%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2654%26epage%3D2657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Peterson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Be, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubinska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span> </span><span class="NLM_article-title">Discovery of triazine-benzimidazoles as selective inhibitors of mTOR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2064</span><span class="NLM_x">–</span> <span class="NLM_lpage">2070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2064-2070&author=E.+A.+Petersonauthor=P.+S.+Andrewsauthor=X.+Beauthor=A.+A.+Boezioauthor=T.+L.+Bushauthor=A.+C.+Chengauthor=J.+R.+Coatsauthor=A.+E.+Collettiauthor=K.+W.+Copelandauthor=M.+DuPontauthor=R.+Graceffaauthor=B.+Grubinskaauthor=J.-C.+Harmangeauthor=J.+L.+Kimauthor=E.+L.+Mulladyauthor=P.+Olivieriauthor=L.+B.+Schenkelauthor=M.+K.+Stantonauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=T.+Caiauthor=D.+S.+La&title=Discovery+of+triazine-benzimidazoles+as+selective+inhibitors+of+mTOR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DBe%26aufirst%3DX.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBush%26aufirst%3DT.%2BL.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DCoats%26aufirst%3DJ.%2BR.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DDuPont%26aufirst%3DM.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGrubinska%26aufirst%3DB.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DStanton%26aufirst%3DM.%2BK.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DLa%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520of%2520triazine-benzimidazoles%2520as%2520selective%2520inhibitors%2520of%2520mTOR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2064%26epage%3D2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4036</span><span class="NLM_x">–</span> <span class="NLM_lpage">4040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4036-4040&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=H.+G.+Choiauthor=D.+L.+Wallerauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+and+optimization+of+potent+and+selective+benzonaphthyridinone+analogs+as+small+molecule+mTOR+inhibitors+with+improved+mouse+microsome+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DWaller%26aufirst%3DD.%2BL.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520and%2520selective%2520benzonaphthyridinone%2520analogs%2520as%2520small%2520molecule%2520mTOR%2520inhibitors%2520with%2520improved%2520mouse%2520microsome%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4036%26epage%3D4040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[<i>h</i>][1,6]naphthyridin-2(1<i>H</i>)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1473</span><span class="NLM_x">–</span> <span class="NLM_lpage">1480</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101520v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1473-1480&author=Q.+Liuauthor=J.+Wangauthor=S.+A.+Kangauthor=C.+C.+Thoreenauthor=W.+Hurauthor=T.+Ahmedauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=Discovery+of+9-%286-aminopyridin-3-yl%29-1-%283-%28trifluoromethyl%29phenyl%29benzo%5Bh%5D%5B1%2C6%5Dnaphthyridin-2%281H%29-one+%28Torin2%29+as+a+potent%2C+selective%2C+and+orally+available+mammalian+target+of+rapamycin+%28mTOR%29+inhibitor+for+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8r&amp;dbid=16384&amp;doi=10.1021%2Fjm101520v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101520v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25209-%25286-aminopyridin-3-yl%2529-1-%25283-%2528trifluoromethyl%2529phenyl%2529benzo%255Bh%255D%255B1%252C6%255Dnaphthyridin-2%25281H%2529-one%2520%2528Torin2%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520inhibitor%2520for%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1473%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coate, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares-Greco, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span> </span><span class="NLM_article-title">Imidazo[1,5-<i>a</i>]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2092</span><span class="NLM_x">–</span> <span class="NLM_lpage">2097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2092-2097&author=A.+P.+Crewauthor=S.+V.+Bhagwatauthor=H.+Dongauthor=M.+A.+Bittnerauthor=A.+Chanauthor=X.+Chenauthor=H.+Coateauthor=A.+Cookeauthor=P.+C.+Gokhaleauthor=A.+Hondaauthor=M.+Jinauthor=J.+Kahlerauthor=C.+Mantisauthor=M.+J.+Mulvihillauthor=P.+A.+Tavares-Grecoauthor=B.+Volkauthor=J.+Wangauthor=D.+S.+Wernerauthor=L.+D.+Arnoldauthor=J.+A.+Pachterauthor=R.+Wildauthor=N.+W.+Gibson&title=Imidazo%5B1%2C5-a%5Dpyrazines%3A+orally+efficacious+inhibitors+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DBhagwat%26aufirst%3DS.%2BV.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DBittner%26aufirst%3DM.%2BA.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCoate%26aufirst%3DH.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DGokhale%26aufirst%3DP.%2BC.%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DMantis%26aufirst%3DC.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DTavares-Greco%26aufirst%3DP.%2BA.%26aulast%3DVolk%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWerner%26aufirst%3DD.%2BS.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26aulast%3DWild%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26atitle%3DImidazo%255B1%252C5-a%255Dpyrazines%253A%2520orally%2520efficacious%2520inhibitors%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2092%26epage%3D2097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Bhagwat, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokhale, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudkin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pachter, J. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8t&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1158%2F1535-7163.MCT-10-1099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8t&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=21673091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8t&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1394-1406&author=S.+V.+Bhagwatauthor=P.+C.+Gokhaleauthor=A.+P.+Crewauthor=A.+Cookeauthor=Y.+Yaoauthor=C.+Mantisauthor=J.+Kahlerauthor=J.+Workmanauthor=M.+Bittnerauthor=L.+Dudkinauthor=D.+M.+Epsteinauthor=N.+W.+Gibsonauthor=R.+Wildauthor=L.+D.+Arnoldauthor=P.+J.+Houghtonauthor=J.+A.+Pachter&title=Preclinical+characterization+of+OSI-027%2C+a+potent+and+selective+inhibitor+of+mTORC1+and+mTORC2%3A+distinct+from+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8tR"><div class="casContent"><span class="casTitleNuber">8t</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin</span></div><div class="casAuthors">Bhagwat, Shripad V.; Gokhale, Prafulla C.; Crew, Andrew P.; Cooke, Andy; Yao, Yan; Mantis, Christine; Kahler, Jennifer; Workman, Jennifer; Bittner, Mark; Dudkin, Lorina; Epstein, David M.; Gibson, Neil W.; Wild, Robert; Arnold, Lee D.; Houghton, Peter J.; Pachter, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1394-1406</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway is frequently activated in human cancers, and mTOR is a clin. validated target.  MTOR forms two distinct multiprotein complexes, mTORC1 and mTORC2, which regulate cell growth, metab., proliferation, and survival.  Rapamycin and its analogs partially inhibit mTOR through allosteric binding to mTORC1, but not mTORC2, and have shown clin. utility in certain cancers.  Here, we report the preclin. characterization of OSI-027, a selective and potent dual inhibitor of mTORC1 and mTORC2 with biochem. IC50 values of 22 nmol/L and 65 nmol/L, resp.  OSI-027 shows more than 100-fold selectivity for mTOR relative to PI3Kα, PI3Kβ, PI3Kγ, and DNA-PK.  OSI-027 inhibits phosphorylation of the mTORC1 substrates 4E-BP1 and S6K1 as well as the mTORC2 substrate AKT in diverse cancer models in vitro and in vivo.  OSI-027 and OXA-01 (close analog of OSI-027) potently inhibit proliferation of several rapamycin-sensitive and -insensitive nonengineered and engineered cancer cell lines and also, induce cell death in tumor cell lines with activated PI3K-AKT signaling.  OSI-027 shows concn.-dependent pharmacodynamic effects on phosphorylation of 4E-BP1 and AKT in tumor tissue with resulting tumor growth inhibition.  OSI-027 shows robust antitumor activity in several different human xenograft models representing various histologies.  Furthermore, in COLO 205 and GEO colon cancer xenograft models, OSI-027 shows superior efficacy compared with rapamycin.  Our results further support the important role of mTOR as a driver of tumor growth and establish OSI-027 as a potent anticancer agent.  OSI-027 is currently in phase I clin. trials in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLyA6Bn0nZqbVg90H21EOLACvtfcHk0lji15YTg-A-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSqtLnF&md5=8d91103e12ab5c632571f17510b3ee7f</span></div><a href="/servlet/linkout?suffix=cit8t&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-1099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-1099%26sid%3Dliteratum%253Aachs%26aulast%3DBhagwat%26aufirst%3DS.%2BV.%26aulast%3DGokhale%26aufirst%3DP.%2BC.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DMantis%26aufirst%3DC.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DWorkman%26aufirst%3DJ.%26aulast%3DBittner%26aufirst%3DM.%26aulast%3DDudkin%26aufirst%3DL.%26aulast%3DEpstein%26aufirst%3DD.%2BM.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DWild%26aufirst%3DR.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DPachter%26aufirst%3DJ.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520OSI-027%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%253A%2520distinct%2520from%2520rapamycin%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1394%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Mortensen, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin-Ninkovic, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevlin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khambatta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisonette, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fultz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankar, S.</span><span> </span><span class="NLM_article-title">Discovery and SAR exploration of a novel series of imidazo[4,5-<i>b</i>]pyrazin-2-ones as potent and selective mTOR kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6793</span><span class="NLM_x">–</span> <span class="NLM_lpage">6799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8u&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2011.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8u&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=21978683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8u&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6793-6799&author=D.+S.+Mortensenauthor=S.+M.+Perrin-Ninkovicauthor=R.+Harrisauthor=B.+G.+S.+Leeauthor=G.+Shevlinauthor=M.+Hickmanauthor=G.+Khambattaauthor=R.+R.+Bisonetteauthor=K.+E.+Fultzauthor=S.+Sankar&title=Discovery+and+SAR+exploration+of+a+novel+series+of+imidazo%5B4%2C5-b%5Dpyrazin-2-ones+as+potent+and+selective+mTOR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8uR"><div class="casContent"><span class="casTitleNuber">8u</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Mortensen, Deborah S.; Perrin-Ninkovic, Sophie M.; Harris, Roy; Lee, Branden G. S.; Shevlin, Graziella; Hickman, Matt; Khambatta, Gody; Bisonette, Rene R.; Fultz, Kimberly E.; Sankar, Sabita</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6793-6799</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report here the discovery of a novel series of selective mTOR kinase inhibitors.  A series of imidazo[4,5-b]pyrazin-2-ones, represented by screening hit 1, was developed into lead compds. with excellent mTOR potency and exquisite kinase selectivity.  Potent compds. from this series show >1000-fold selectivity over the related PI3Kα lipid kinase.  Further, compds. such as 2 achieve mTOR pathway inhibition, blocking both mTORC1 and mTORC2 signaling, in PC3 cancer cells as measured by inhibition of pS6 and pAkt (S473).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWly4sBJXgerVg90H21EOLACvtfcHk0lji15YTg-A-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktr3P&md5=d422a7d505c1032951547d997ac2e033</span></div><a href="/servlet/linkout?suffix=cit8u&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DMortensen%26aufirst%3DD.%2BS.%26aulast%3DPerrin-Ninkovic%26aufirst%3DS.%2BM.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DB.%2BG.%2BS.%26aulast%3DShevlin%26aufirst%3DG.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DKhambatta%26aufirst%3DG.%26aulast%3DBisonette%26aufirst%3DR.%2BR.%26aulast%3DFultz%26aufirst%3DK.%2BE.%26aulast%3DSankar%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520SAR%2520exploration%2520of%2520a%2520novel%2520series%2520of%2520imidazo%255B4%252C5-b%255Dpyrazin-2-ones%2520as%2520potent%2520and%2520selective%2520mTOR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6793%26epage%3D6799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Finlay, M. R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchlow, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dishington, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillery, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glossop, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamont, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, A. M.</span><span> </span><span class="NLM_article-title">Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4163</span><span class="NLM_x">–</span> <span class="NLM_lpage">4168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4163-4168&author=M.+R.+V.+Finlayauthor=D.+Buttarauthor=S.+E.+Critchlowauthor=A.+P.+Dishingtonauthor=S.+M.+Filleryauthor=E.+Fisherauthor=S.+C.+Glossopauthor=M.+A.+Grahamauthor=T.+Johnsonauthor=G.+M.+Lamontauthor=S.+Muttonauthor=P.+Perkinsauthor=K.+G.+Pikeauthor=A.+M.+Slater&title=Sulfonyl-morpholino-pyrimidines%3A+SAR+and+development+of+a+novel+class+of+selective+mTOR+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8v&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DButtar%26aufirst%3DD.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DDishington%26aufirst%3DA.%2BP.%26aulast%3DFillery%26aufirst%3DS.%2BM.%26aulast%3DFisher%26aufirst%3DE.%26aulast%3DGlossop%26aufirst%3DS.%2BC.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DLamont%26aufirst%3DG.%2BM.%26aulast%3DMutton%26aufirst%3DS.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DSlater%26aufirst%3DA.%2BM.%26atitle%3DSulfonyl-morpholino-pyrimidines%253A%2520SAR%2520and%2520development%2520of%2520a%2520novel%2520class%2520of%2520selective%2520mTOR%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4163%26epage%3D4168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Peterson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boezio, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuPont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubinska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellwagen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span> </span><span class="NLM_article-title">Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4967</span><span class="NLM_x">–</span> <span class="NLM_lpage">4974</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4967-4974&author=E.+A.+Petersonauthor=A.+A.+Boezioauthor=P.+S.+Andrewsauthor=C.+M.+Boezioauthor=T.+L.+Bushauthor=A.+C.+Chengauthor=D.+Choquetteauthor=J.+R.+Coatsauthor=A.+E.+Collettiauthor=K.+W.+Copelandauthor=M.+DuPontauthor=R.+Graceffaauthor=B.+Grubinskaauthor=J.+L.+Kimauthor=R.+T.+Lewisauthor=J.+Liuauthor=E.+L.+Mulladyauthor=M.+H.+Potashmanauthor=K.+Romeroauthor=P.+L.+Shafferauthor=M.+K.+Stantonauthor=J.+C.+Stellwagenauthor=Y.+Tefferaauthor=S.+Yiauthor=T.+Caiauthor=D.+S.+La&title=Discovery+and+optimization+of+potent+and+selective+imidazopyridine+and+imidazopyridazine+mTOR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8w&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DBoezio%26aufirst%3DC.%2BM.%26aulast%3DBush%26aufirst%3DT.%2BL.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoats%26aufirst%3DJ.%2BR.%26aulast%3DColletti%26aufirst%3DA.%2BE.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DDuPont%26aufirst%3DM.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGrubinska%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DRomero%26aufirst%3DK.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26aulast%3DStanton%26aufirst%3DM.%2BK.%26aulast%3DStellwagen%26aufirst%3DJ.%2BC.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DYi%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DT.%26aulast%3DLa%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520potent%2520and%2520selective%2520imidazopyridine%2520and%2520imidazopyridazine%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4967%26epage%3D4974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Liu, K. K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span> </span><span class="NLM_article-title">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5114</span><span class="NLM_x">–</span> <span class="NLM_lpage">5117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8x&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.1016%2Fj.bmcl.2012.05.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8x&amp;dbid=8&amp;doi=10.1021%2Fjm400194n&amp;key=22765900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8x&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5114-5117&author=K.+K.+C.+Liuauthor=S.+Baileyauthor=D.+M.+Dinhauthor=H.+Lamauthor=C.+Liauthor=P.+A.+Wellsauthor=M.-J.+Yinauthor=A.+Zou&title=Conformationally-restricted+cyclic+sulfones+as+potent+and+selective+mTOR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8xR"><div class="casContent"><span class="casTitleNuber">8x</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Liu, Kevin K.-C.; Bailey, Simon; Dinh, Dac M.; Lam, Hieu; Li, Chunze; Wells, Peter A.; Yin, Min-Jean; Zou, Aihua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5114-5117</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel conformationally-restricted mTOR kinase inhibitors with cyclic sulfone scaffold were designed.  Synthesis and structure-activity relationship (SAR) studies are described with emphasis on optimization of the mTOR potency and selectivity against class I PI3Kα kinase.  PF-05139962 I was identified with excellent mTOR biochem. inhibition, cellular potency, kinase selectivity and in vitro ADME properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmuwjN05w_4LVg90H21EOLACvtfcHk0lhV3Kxirx-9rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D&md5=c1abe951c4d17f22a2301004eff55d91</span></div><a href="/servlet/linkout?suffix=cit8x&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.104%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.%2BC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DZou%26aufirst%3DA.%26atitle%3DConformationally-restricted%2520cyclic%2520sulfones%2520as%2520potent%2520and%2520selective%2520mTOR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5114%26epage%3D5117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robarge, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3426</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200215y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3426-3435&author=F.+Cohenauthor=P.+Bergeronauthor=E.+Blackwoodauthor=K.+K.+Bowmanauthor=H.+Chenauthor=A.+G.+DiPasqualeauthor=J.+A.+Eplerauthor=M.+F.+T.+Koehlerauthor=K.+Lauauthor=C.+Lewisauthor=L.+Liuauthor=C.+Q.+Lyauthor=S.+Malekauthor=J.+Nonomiyaauthor=D.+F.+Ortwineauthor=Z.+Peiauthor=K.+D.+Robargeauthor=S.+Siderisauthor=L.+Trinhauthor=T.+Truongauthor=J.+Wuauthor=X.+Zhaoauthor=J.+P.+Lyssikatos&title=Potent%2C+selective%2C+and+orally+bioavailable+inhibitors+of+mammalian+target+of+rapamycin+%28mTOR%29+kinase+based+on+a+quaternary+substituted+dihydrofuropyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm200215y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200215y%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DEpler%26aufirst%3DJ.%2BA.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DRobarge%26aufirst%3DK.%2BD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DPotent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%2520based%2520on%2520a%2520quaternary%2520substituted%2520dihydrofuropyrimidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3426%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Potent, selective and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase domain exhibiting single agent antiproliferative activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10958</span><span class="NLM_x">–</span> <span class="NLM_lpage">10971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301389h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10958-10971&author=M.+F.+T.+Koehlerauthor=P.+Bergeronauthor=E.+Blackwoodauthor=K.+K.+Bowmanauthor=Y.-H.+Chenauthor=G.+Deshmukhauthor=X.+Dingauthor=J.+Eplerauthor=K.+Lauauthor=L.+Leeauthor=L.+Liuauthor=C.+Lyauthor=S.+Malekauthor=J.+Nonomiyaauthor=J.+Oehauthor=D.+F.+Ortwineauthor=D.+Sampathauthor=S.+Siderisauthor=L.+Trinhauthor=T.+Truongauthor=J.+Wuauthor=Z.+Peiauthor=J.+P.+Lyssikatos&title=Potent%2C+selective+and+orally+bioavailable+inhibitors+of+mammalian+target+of+rapamycin+%28mTOR%29+kinase+domain+exhibiting+single+agent+antiproliferative+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm301389h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301389h%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DY.-H.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DEpler%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLy%26aufirst%3DC.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOeh%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DPotent%252C%2520selective%2520and%2520orally%2520bioavailable%2520inhibitors%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520kinase%2520domain%2520exhibiting%2520single%2520agent%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10958%26epage%3D10971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijapurkar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span> </span><span class="NLM_article-title">Discovery and biological profiling of potent and selective mTOR inhibitor GDC-0349</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3003132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=103-107&author=Z.+Peiauthor=E.+Blackwoodauthor=L.+Liuauthor=S.+Malekauthor=M.+Belvinauthor=M.+F.+T.+Koehlerauthor=D.+F.+Ortwineauthor=H.+Chenauthor=F.+Cohenauthor=J.+R.+Kennyauthor=P.+Bergeronauthor=K.+Lauauthor=C.+Lyauthor=X.+Zhaoauthor=A.+A.+Estradaauthor=T.+Truongauthor=J.+A.+Eplerauthor=J.+Nonomiyaauthor=L.+Trinhauthor=S.+Siderisauthor=J.+Lesnickauthor=L.+Baoauthor=U.+Vijapurkarauthor=S.+Mukadamauthor=S.+Tayauthor=G.+Deshmukhauthor=Y.-H.+Chenauthor=X.+Dingauthor=L.+Friedmanauthor=J.+P.+Lyssikatos&title=Discovery+and+biological+profiling+of+potent+and+selective+mTOR+inhibitor+GDC-0349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fml3003132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003132%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DBelvin%26aufirst%3DM.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLy%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DTruong%26aufirst%3DT.%26aulast%3DEpler%26aufirst%3DJ.%2BA.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DTrinh%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DVijapurkar%26aufirst%3DU.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.-H.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520biological%2520profiling%2520of%2520potent%2520and%2520selective%2520mTOR%2520inhibitor%2520GDC-0349%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D103%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Orr, S. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure–activity relationships and discovery strategies to mitigate drug–drug interaction risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4896</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+M.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure%E2%80%93activity+relationships+and+discovery+strategies+to+mitigate+drug%E2%80%93drug+interaction+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug%25E2%2580%2593drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, S. R.</span><span> </span><span class="NLM_article-title">Statistical methods for analysis of time-dependent inhibition of cytochrome P450 enzymes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2289-2296&author=P.+Yatesauthor=H.+Engauthor=L.+Diauthor=S.+R.+Obach&title=Statistical+methods+for+analysis+of+time-dependent+inhibition+of+cytochrome+P450+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYates%26aufirst%3DP.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DObach%26aufirst%3DS.%2BR.%26atitle%3DStatistical%2520methods%2520for%2520analysis%2520of%2520time-dependent%2520inhibition%2520of%2520cytochrome%2520P450%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2289%26epage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galetin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, S. C.</span><span> </span><span class="NLM_article-title">Drug–drug interaction potential of marketed oncology drugs: in vitro assessment of time-dependent cytochrome P450 inhibition, reactive metabolite formation and drug–drug interaction prediction</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1960</span><span class="NLM_x">–</span> <span class="NLM_lpage">1976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=1960-1976&author=J.+R.+Kennyauthor=S.+Mukadamauthor=C.+Zhangauthor=S.+Tayauthor=C.+Collinsauthor=A.+Galetinauthor=S.+C.+Khojasteh&title=Drug%E2%80%93drug+interaction+potential+of+marketed+oncology+drugs%3A+in+vitro+assessment+of+time-dependent+cytochrome+P450+inhibition%2C+reactive+metabolite+formation+and+drug%E2%80%93drug+interaction+prediction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DGaletin%26aufirst%3DA.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26atitle%3DDrug%25E2%2580%2593drug%2520interaction%2520potential%2520of%2520marketed%2520oncology%2520drugs%253A%2520in%2520vitro%2520assessment%2520of%2520time-dependent%2520cytochrome%2520P450%2520inhibition%252C%2520reactive%2520metabolite%2520formation%2520and%2520drug%25E2%2580%2593drug%2520interaction%2520prediction%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D1960%26epage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bredt, J.</span><span> </span><span class="NLM_article-title">Über sterische hinderung in brückenringen (bredtsche regel) und über die meso-trans-stellung in kondensierten ringsystemen des hexamethylens</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1924</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=1924&pages=1-13&author=J.+Bredt&title=%C3%9Cber+sterische+hinderung+in+br%C3%BCckenringen+%28bredtsche+regel%29+und+%C3%BCber+die+meso-trans-stellung+in+kondensierten+ringsystemen+des+hexamethylens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBredt%26aufirst%3DJ.%26atitle%3D%25C3%259Cber%2520sterische%2520hinderung%2520in%2520br%25C3%25BCckenringen%2520%2528bredtsche%2520regel%2529%2520und%2520%25C3%25BCber%2520die%2520meso-trans-stellung%2520in%2520kondensierten%2520ringsystemen%2520des%2520hexamethylens%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1924%26volume%3D437%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><div class="note"><p class="first last">For a review of this topic, see the following:</p></div><span class="NLM_contrib-group">Shea, K. J.</span><span> </span><span class="NLM_article-title">Recent developments in the synthesis, structure and chemistry of bridgehead alkenes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1980&pages=1683-1715&author=K.+J.+Shea&title=Recent+developments+in+the+synthesis%2C+structure+and+chemistry+of+bridgehead+alkenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShea%26aufirst%3DK.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520the%2520synthesis%252C%2520structure%2520and%2520chemistry%2520of%2520bridgehead%2520alkenes%26jtitle%3DTetrahedron%26date%3D1980%26volume%3D36%26spage%3D1683%26epage%3D1715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgUo5-cvDd9PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0lhHJxXE5crDUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Movassaghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span> </span><span class="NLM_article-title">Single-step synthesis of pyrimidine derivatives</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">14254</span><span class="NLM_x">–</span> <span class="NLM_lpage">14255</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja066405m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKitbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14254-14255&author=M.+Movassaghiauthor=M.+D.+Hill&title=Single-step+synthesis+of+pyrimidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Single-step synthesis of pyrimidine derivatives</span></div><div class="casAuthors">Movassaghi, Mohammad; Hill, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">14254-14255</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A single-step conversion of various N-vinyl and N-aryl amides to the corresponding pyrimidine and quinazoline derivs., resp, e.g., I (R = H, MeO or NO2) was described.  The process involved amide activation with 2-chloropyridine and trifluoromethanesulfonic anhydride followed by nitrile addn. into the reactive intermediate and cycloisomerization.  The use of this chem. with sensitive N-vinyl amides and epimerizable substrates in addn. to a wide range of functional groups was noteworthy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVLTLAyIDRWrVg90H21EOLACvtfcHk0lhHJxXE5crDUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKitbbJ&md5=66ca82afed67237dd52f26996ce32e7d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja066405m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja066405m%26sid%3Dliteratum%253Aachs%26aulast%3DMovassaghi%26aufirst%3DM.%26aulast%3DHill%26aufirst%3DM.%2BD.%26atitle%3DSingle-step%2520synthesis%2520of%2520pyrimidine%2520derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14254%26epage%3D14255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ahmad, O. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Movassaghi, M.</span><span> </span><span class="NLM_article-title">Synthesis of densely substituted pyrimidine derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">8460</span><span class="NLM_x">–</span> <span class="NLM_lpage">8463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9017149" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=8460-8463&author=O.+K.+Ahmadauthor=M.+D.+Hillauthor=M.+Movassaghi&title=Synthesis+of+densely+substituted+pyrimidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Densely Substituted Pyrimidine Derivatives</span></div><div class="casAuthors">Ahmad, Omar K.; Hill, Matthew D.; Movassaghi, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8460-8463</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using 2-chloropyridine and triflic anhydride as activating agents, unsatd. or arom. amides RCONHR1 [R = cyclohexyl, Ph, MeO2C, (4-MeOC6H4CH2)2N, MeON(Me), PhO; R1 = 1-cyclohexen-1-yl, Ph, 4-MeC6H4, 4-MeOC6H4, PhCH:CH] undergo cyclocondensation reactions with cyanamides, cyanic acid esters, cyanogen bromide, or cyclohexanecarbonitrile R2CN (R2 = 4-morpholinyl, phthalimidyl, PhO, MeS, Br, cyclohexyl) to give pyrimidines and quinazolines such as I (R3 = MeS, Br) in 54-99% yields.  I (R3 = MeS, Br) are converted to I (R3 = H, BuNH, H2N) and the keto tautomer of I (R3 = HO) in 59-100% yields.  Limitations on the method are disclosed.  The method allows access to heterocycles difficult or impossible to prep. by other means.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiu0aNb5KOUrVg90H21EOLACvtfcHk0lgXrztlGDHJxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artL%252FN&md5=a936dbd2b4f72c5cf5f328358b6648c3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo9017149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9017149%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DO.%2BK.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DMovassaghi%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520densely%2520substituted%2520pyrimidine%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D8460%26epage%3D8463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jean, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span> </span><span class="NLM_article-title">Access to saturated fused pyrimidine derivatives via a flexible <i>N</i>-vinyl tertiary enamide synthesis</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=2387-2391&author=A.+A.+Estradaauthor=J.+P.+Lyssikatosauthor=F.+St-Jeanauthor=P.+Bergeron&title=Access+to+saturated+fused+pyrimidine+derivatives+via+a+flexible+N-vinyl+tertiary+enamide+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DSt-Jean%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DP.%26atitle%3DAccess%2520to%2520saturated%2520fused%2520pyrimidine%2520derivatives%2520via%2520a%2520flexible%2520N-vinyl%2520tertiary%2520enamide%2520synthesis%26jtitle%3DSynlett%26date%3D2011%26volume%3D16%26spage%3D2387%26epage%3D2391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.-Y.+Zhu&title=Discovery+of+%28thienopyrimidin-2-yl%29aminopyrimidines+as+potent%2C+selective%2C+and+orally+available+pan-PI3-kinase+and+dual+pan-PI3-kinase%2FmTOR+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.-Y.%26atitle%3DDiscovery%2520of%2520%2528thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520pan-PI3-kinase%2520and%2520dual%2520pan-PI3-kinase%252FmTOR%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarosa, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span> </span><span class="NLM_article-title">Evaluation of time-dependent cytochrome P450 inhibition in a high-throughput, automated assay: introducing a novel area under the curve shift approach</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm400194n&amp;key=10.2174%2F187231212800229309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=45-53&author=S.+Mukadamauthor=S.+Tayauthor=D.+Tranauthor=L.+Wangauthor=E.+M.+Delarosaauthor=S.+C.+Khojastehauthor=J.+Halladayauthor=J.+R.+Kenny&title=Evaluation+of+time-dependent+cytochrome+P450+inhibition+in+a+high-throughput%2C+automated+assay%3A+introducing+a+novel+area+under+the+curve+shift+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F187231212800229309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231212800229309%26sid%3Dliteratum%253Aachs%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDelarosa%26aufirst%3DE.%2BM.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26atitle%3DEvaluation%2520of%2520time-dependent%2520cytochrome%2520P450%2520inhibition%2520in%2520a%2520high-throughput%252C%2520automated%2520assay%253A%2520introducing%2520a%2520novel%2520area%2520under%2520the%2520curve%2520shift%2520approach%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2012%26volume%3D6%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The difference in antiproliferative activities for <b>11</b> and <b>15</b> cannot be definitively attributed to plasma protein binding, as there are differences across species between these two compounds and protein binding in fetal bovine serum (10% FBS was used in the antiproliferative assays) was not determined.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Grunwald, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGraffenried, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrichs, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span> </span><span class="NLM_article-title">Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6141</span><span class="NLM_x">–</span> <span class="NLM_lpage">6145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6141-6145&author=V.+Grunwaldauthor=L.+DeGraffenriedauthor=D.+Russelauthor=W.+E.+Friedrichsauthor=R.+B.+Rayauthor=M.+Hidalgo&title=Inhibitors+of+mTOR+reverse+doxorubicin+resistance+conferred+by+PTEN+status+in+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrunwald%26aufirst%3DV.%26aulast%3DDeGraffenried%26aufirst%3DL.%26aulast%3DRussel%26aufirst%3DD.%26aulast%3DFriedrichs%26aufirst%3DW.%2BE.%26aulast%3DRay%26aufirst%3DR.%2BB.%26aulast%3DHidalgo%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520mTOR%2520reverse%2520doxorubicin%2520resistance%2520conferred%2520by%2520PTEN%2520status%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6141%26epage%3D6145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Thompson, W.; Claremon, D. A.; Munson, P. M.; Phillips, B.</span><span> </span><span class="NLM_article-title">8-Aza-bicyclo[3.2.1]octane NMDA/NR2B Antagonists</span>. WO 2001032179,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=W.+Thompson&author=D.+A.+Claremon&author=P.+M.+Munson&author=B.+Phillips&title=8-Aza-bicyclo%5B3.2.1%5Doctane+NMDA%2FNR2B+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%26atitle%3D8-Aza-bicyclo%255B3.2.1%255Doctane%2520NMDA%252FNR2B%2520Antagonists%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">For the assignment of stereochemistry of 8-benzyl-8-azabicyclo[3.2.1]octan-2-one isomers via specific rotation, see the following:</p></div><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, H.</span><span> </span><span class="NLM_article-title">Enantiospecific synthesis of natural (−)-cocaine and unnatural (+)-cocaine from <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-glutamic acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">4069</span><span class="NLM_x">–</span> <span class="NLM_lpage">4078</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo980153t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=4069-4078&author=R.+Linauthor=J.+Castellsauthor=H.+Rapoport&title=Enantiospecific+synthesis+of+natural+%28%E2%88%92%29-cocaine+and+unnatural+%28%2B%29-cocaine+from+d-+and+l-glutamic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo980153t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo980153t%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DR.%26aulast%3DCastells%26aufirst%3DJ.%26aulast%3DRapoport%26aufirst%3DH.%26atitle%3DEnantiospecific%2520synthesis%2520of%2520natural%2520%2528%25E2%2588%2592%2529-cocaine%2520and%2520unnatural%2520%2528%252B%2529-cocaine%2520from%2520d-%2520and%2520l-glutamic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D4069%26epage%3D4078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Denmark, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuhashi, H.</span><span> </span><span class="NLM_article-title">Chiral fluoro ketones for catalytic asymmetric epoxidation of alkenes with oxone</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3479</span><span class="NLM_x">–</span> <span class="NLM_lpage">3486</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020050h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=3479-3486&author=S.+E.+Denmarkauthor=H.+Matsuhashi&title=Chiral+fluoro+ketones+for+catalytic+asymmetric+epoxidation+of+alkenes+with+oxone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo020050h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020050h%26sid%3Dliteratum%253Aachs%26aulast%3DDenmark%26aufirst%3DS.%2BE.%26aulast%3DMatsuhashi%26aufirst%3DH.%26atitle%3DChiral%2520fluoro%2520ketones%2520for%2520catalytic%2520asymmetric%2520epoxidation%2520of%2520alkenes%2520with%2520oxone%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D3479%26epage%3D3486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">7-Aza pyrimidoaminotropanes were synthesized using <i>N</i>-Troc as tropane protecting group; see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">MMP-cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3001138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1138-1145&author=X.+Huauthor=Y.+Huauthor=M.+Vogtauthor=D.+Stumpfeauthor=J.+Bajorath&title=MMP-cliffs%3A+systematic+identification+of+activity+cliffs+on+the+basis+of+matched+molecular+pairs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs</span></div><div class="casAuthors">Hu, Xiaoying; Hu, Ye; Vogt, Martin; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1145</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity cliffs are generally defined as pairs of structurally similar compds. having large differences in potency.  The anal. of activity cliffs is of general interest because structure-activity relationship (SAR) determinants can often be deduced from them.  Crit. questions for the study of activity cliffs include how similar compds. should be to qualify as cliff partners, how similarity should be assessed, and how large potency differences between participating compds. should be.  Thus far, activity cliffs have mostly been defined on the basis of calcd. Tanimoto similarity values using structural descriptors, esp. 2D fingerprints.  As any theor. assessment of mol. similarity, this approach has its limitations.  For example, calcd. Tanimoto similarities might often be difficult to reconcile and interpret from a chem. perspective, a point of critique frequently raised in medicinal chem.  Herein, we have explored activity cliffs by considering well-defined substructure replacements instead of calcd. similarity values.  For this purpose, the matched mol. pair (MMP) formalism has been applied.  MMPs were systematically derived from public domain compds., and activity cliffs were extd. from them, termed MMP-cliffs.  The frequency of cliff formation was detd. for compds. active against different targets, MMP-cliffs were analyzed in detail, and re-evaluated on the basis of Tanimoto similarity.  In many instances, chem. intuitive activity cliffs were only detected on the basis of MMPs, but not Tanimoto similarity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCYSOxNqPjGbVg90H21EOLACvtfcHk0lh5KG8MIVNW1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D&md5=958a76d85d0a06424b43eb1b694cf3ca</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci3001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3001138%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DVogt%26aufirst%3DM.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DMMP-cliffs%253A%2520systematic%2520identification%2520of%2520activity%2520cliffs%2520on%2520the%2520basis%2520of%2520matched%2520molecular%2520pairs%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1138%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">The power of MMPA and a teaching lesson in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1815</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300163y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1815-1816&author=K.+Muller&title=The+power+of+MMPA+and+a+teaching+lesson+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm300163y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300163y%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DThe%2520power%2520of%2520MMPA%2520and%2520a%2520teaching%2520lesson%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1815%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Exploring activity cliffs in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2932</span><span class="NLM_x">–</span> <span class="NLM_lpage">2942</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201706b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2932-2942&author=D.+Stumpfeauthor=J.+Bajorath&title=Exploring+activity+cliffs+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Activity Cliffs in Medicinal Chemistry</span></div><div class="casAuthors">Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2932-2942</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, structure-activity relationships (SARs) have increasingly been studied through mining of large compd. data sets, leading to a renaissance of the activity landscape concept.  In general terms, an activity landscape is defined as any graphical representation that integrates similarity and potency relationships between compds. sharing a specific activity.  From activity landscape representations of different design, both global and local SAR features present in compd. data sets can be extd.  Modeling and rationalizing activity landscapes require the application of computational methods.  As such, the activity landscape concept is of comparable relevance for chemoinformatics (having a strong focus on data mining and representation) and medicinal chem. (given its immediate relevance for SAR anal.).  Herein, we describe in detail the multifaceted nature of activity cliffs, discuss underlying scientific concepts, and explain how their individual or systematic anal. might (or might not) provide useful information for medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1wydp65qQLVg90H21EOLACvtfcHk0lh5KG8MIVNW1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D&md5=ceddd1de5798b585d6381ac18ba67fc9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm201706b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201706b%26sid%3Dliteratum%253Aachs%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DExploring%2520activity%2520cliffs%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2932%26epage%3D2942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400194n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0lh5G2EqWn_iIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Chemical transformations that yield compounds with distinct activity profiles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=523-527&author=Y.+Huauthor=J.+Bajorath&title=Chemical+transformations+that+yield+compounds+with+distinct+activity+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fml2000609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000609%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DChemical%2520transformations%2520that%2520yield%2520compounds%2520with%2520distinct%2520activity%2520profiles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D523%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">At the time of the PK/PD experiment with <b>20</b>, it was already established from multiple experiments with other mTOR small molecule inhibitors that a single 6 h time point was sufficient to predict the mED.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">mED is defined as the dose required to achieve ED<sub>50</sub> when constrained to 0–100% TGI.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE','PDB','3IBE'); return false;">PDB: 3IBE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a href="/doi/suppl/10.1021/jm400194n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66865"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures (compound <b>17</b>) and X-ray ORTEP plot and data collection and analysis. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400194n/suppl_file/jm400194n_si_001.pdf">jm400194n_si_001.pdf (540.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400194n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm400194n%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400194n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990f4eba331949","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
